Severity of traumatic brain injury
\r\n\tThis book aims to expose the recent advances in the research and development of chemical and biochemical processes to obtain bio-based chemical compounds and fuels from glycerol.
\r\n\r\n\tChapters dealing with the synthesis and characterization of catalysts (single and mixed hydroxides and oxides, supported catalysts, zeolites, heteropolyacids, pillared-clays, and metal-organic frameworks) and biocatalysts (novel microbial and fungi cultures, immobilized cells, immobilized enzymes, and nanobiocatalysts) to carry out the conversion of glycerol, as well as their testing in discontinuous and continuous stirred reactors, fixed-bed, fluidized-bed, trickle-bed, bubble column, airlift and membrane (bio)reactors are welcome.
\r\n\r\n\tThe book will comprise, but will not be limited to, the homogeneous and heterogeneous chemical reactions of glycerol such as dehydration, hydrogenolysis, partial oxidation, steam- and dry-reforming, glycerol to hydrocarbon fuels and aromatics, (trans)esterification, etherification, halogenation, ammoxidation, as well as supercritical, and photocatalytic processes.
\r\n\r\n\tAdditionally, we hope to cover the bioprocessing of glycerol, including microbial and fungal fermentation and enzymatic reactions to obtain C2-C4 alcohols, diols, hydrogen, methane, organic acids, dihydroxyacetone, biopolymers, and others.
\r\n\tThe book will also deal with the engineering aspects of glycerol processing, such as chemical equilibrium of glycerol reactions, reaction kinetics, (bio)reactor modeling, as well as process simulation and optimization of process variables and reactors.
Traumatic brain injury (TBI) and sleep/wake disorder/s have a complex relationship [1]. A sleep disorder may make a person more prone to TBI by making him or her drowsy or inattentive and therefore more prone to fall or have an accident [2]. A sleep disorder may also make a person with concussion more prone to develop prolonged concussion or post-concussion syndrome in which symptoms last more than 3 weeks or even more than 3 months [3-7]. Likewise a sleep disorder may make them more prone to future concussions and cumulative injury. [7]
Less known and more common and recently recognized is the sleep/wake disorder caused by TBI itself, most simply termed the post traumatic sleep disorder [8-10] We discourage the use of acronym
TBI is a problem of significant and increasing proportions-recently described as a silent epidemic [1]. The number of individuals with TBI is expected to climb with the return of Iraq and Afghanistan veterans back to USA. Just like atom bomb induced cancer was the signature injury of World War II and Agent Orange the signature injury of Vietnam War, TBI is the signature injury of Iraq and Afghanistan wars. [1]
Current estimates indicate that the TBI occurs in 100–400 per 100,000 people per year in North America and Europe. Men are more often affected than women. The most common age group which suffers from traumatic brain injury is 15–35 years. It is the most frequent cause of death between the ages 1-15. It accounts for one third of all injury related deaths in the USA. [8]
The TBI may result from fall, domestic violence, street violence, during birth, motor vehicle accidents, war related injuries, a work related injury or due to sports. Falls and motor vehicle accidents are the most common causes in civilian practice. In developing countries such as India with smaller land size, more population density, lax driving law enforcement and booming motor vehicle growth per capita, motor vehicle accidents are as much as 100 times more common than developed countries such as UK or USA.
TBI could be due to a blunt or a penetrating trauma. The trauma may be direct or indirect such from a nearby explosion-as many as 59 percent soldiers exposed to improvised explosive devices (IEDs) develop TBI. [1]
Contrary to popular belief a significant loss of consciousness (LOC) is not always necessary to make a diagnosis especially in so called mild TBI. Per Center of disease control (CDC), a history of clear cut LOC is seen in only less than 10 percent of patients with concussion. [8]
TBI is often described as acute, subacute and chronic-arbitrarily according to the time elapsed. It is also rated as mild, moderate or severe. Although there is no consensus, many prevailing criteria exist. The departments of defense and veterans affairs [3] have attempted to do this as follows:
\n\t\t\t | |||
Mild | \n\t\t\t13–15 | \n\t\t\t<1 day | \n\t\t\t0–30 minutes | \n\t\t
Moderate | \n\t\t\t9–12 | \n\t\t\t>1 to <7 days | \n\t>30 min to <24 hours | \n
Severe | \n\t3–8 | \n\t>7 days | \n>24 hours | \n
Severity of traumatic brain injury
Only thing mild about
The ACE questionnaire scores the individual on characteristics of Injury (such as severity and type of trauma, LOC, amnesia and presence or absence of seizures), presence and severity of physical symptoms (such as headache, photophobia, dizziness, nausea, blurred vision etc), cognitive symptoms (fogginess, confusion, forgetfulness, perseveration, slow cerebration, lack of concentration), emotional symptoms (irritability, sadness, emotional lability, nervousness) and sleep-related symptoms (such as insomnia, hypersomnia, drowsiness, daytime sleepiness, hyperarousal, flashbacks, nightmares), whether they are increased by exertion and how the person feels as compared to before injury on a seven point sale 0-6) and risk factors such as previous history of concussion, headaches, depression anxiety, sleep disorder or developmental disorder such as ADHD or learning disability. This may also be used for serial follow up.
The military equivalent of this scale is called MACE. A score of 25 or above is considered indicative of concussion in MACE. Symptoms persist from 3 weeks to 3 months and are called post-concussive syndrome if they persist beyond 3 months. Although it is believed that concussion results from biomechanical alterations in the brain and there is no structural damage, neuropathological and MRI data with tractography (diffuse tensor imaging or more sophisticated constrained spherical deconvolution) refute this thesis. If c
TBI may occur alone or may be associated with involvement of not just the brain but also skull, scalp, meninges, eyes, ears, sinuses and other neighborhood structures as well as injuries to neck and body.
Sleep/wake disorders may, in fact, potentially make folks more prone to TBI by making them sleepy and/or inattentive and therefore more likely to be subject of an injury or accident. A preexisting sleep disorder also makes the likelihood of concussion being prolonged and persistent. However, this chapter will mainly deal with the issue of sleep wake disorder/s caused by TBI, a far more common and as yet not well defined problem.
Sleep related problems secondary to chronic TBI have been described anecdotally or in case-report format since 1941. [11-19]. Some commonly reported disorders include hypersomnia, narcolepsy, delayed sleep phase, insomnia, fatigue, alteration of sleep-wake schedule, and movement disorders. It has been found clinically that, insomnia [20], hypersomnia [21-28] and excessive daytime sleepiness (EDS) are common [29, 30] in TBI and may at times occur in the same patient at different intervals from traumatic insult ( see below). Only more recently in last 30 years, attempts have been made to explore this relationship in detail. Guilleminault et al in 1982 [13] described impaired daytime functioning and somnolence in 98 percent of all patients with TBI and further expanded their findings in year 2000, [21] extending their observations to even those with cervical whiplash and commenting on the medico-legal dilemma.
Post-traumatic sleep/wake disorders may significantly impair the rehabilitation potential of an injured individual and need to be accurately diagnosed and treated. Organized literature in this important area is sparse and fragmented. An organized account of these disorders is essential not only to improve the rehabilitation potential of these unfortunate individuals but to protect their medical coverage from auto insurers, as they encounter significant skepticism from adjusters regarding their sleep/wake issues to be causally related to their accidents and injury.
To be perfectly accurate, the sleep/wake disorder may not only result from head injury but neck and bodily injuries may cause or contribute to sleep/wake issues equally or even predominantly. [21]
The post-traumatic sleep/wake disorders may evolve, recede or be persistent after TBI. In a prospective study [31], there was found to be a high prevalence of sleep disorders (46%) and of excessive daytime sleepiness (25%) in 87 subjects at least 3 months after TBI [23]. 47% of the subjects in the aforementioned study was found to have a sleep disorder: OSA (23%), PTH (11%), narcolepsy (6%), or PLMS (7%) and 26% of the subjects had EDS [23]. In immediate post-traumatic period, hypersomnia may be common in hospitalized patients due to medications and interrupted nocturnal sleep due to pain and frequent nursing evaluations. Later on, it may be replaced by insomnia. Parasomnias may occur as well
Watson et al in 2007 [32] found in a prospective study of 514 patients that sleep related symptoms are common during acute phase of TBI. As much as 54 percent patients have daytime somnolence, more in those with more severe injury. They result in daytime somnolence which in turn may lead to poor daytime performance, altered sleep-wake schedule, heightened anxiety, and poor individual sense of well-being, insomnia, and depression. Half of these individuals are still sleepy at the end of one year. Relationship with severity or localization of head injury was disputed by Baumann et al [28] who evaluated patients prospectively as well, but their study ended at 6 months instead of one year in Watson’s study.,. However, similar to Watson study, they also found that quality of life was impaired by these symptoms.. CSF hypocretin-1 was found to be significantly reduced levels in those patients with excessive daytime sleepiness (EDS) symptoms.
Verma et al in 2007 [10] in a retrospective study found that sleep changes and deranged sleep architecture are common in
The possible pathogenetic mechanisms of TBI causing sleep disorders include: direct brain injury, indirect brain injury, collateral damage to neck and back and resulting pain interfering with sleep, [13] weight gain (secondary to head trauma or medications used to treat head trauma or its sequelae such as posttraumatic mood, anxiety or stress disorder), pre-existing genetic propensity for narcolepsy, which may be clinically aggravated or precipitated by head-trauma [11], a pre-existing anatomical abnormality of sleep-related brain mechanisms, oropharyngeal abnormality aggravated by head trauma or resulting weight gain, anatomical abnormalities caused by head trauma such as jaw dislocation, TMJ problems, and brainstem and forebrain lesions induced by TBI.
Direct brain injury was first described by Strich in 1961 [22] as diffuse degeneration of white matter subsequently termed the diffuse axonal injury (DAI). This was later determined in animal experiments to be the consequence of inertial loading of the head by prolonged coronal angular acceleration [23] with brunt of abnormality in septum pellucidum, corpus callosum, deep gray matter and dorso-lateral pons and midbrain, areas closely associated with sleep-wake mechanisms. The biochemical basis of this injury is excitotoxicity, [24] inflammation, [25] free radicals/eicasanoids, [9] hyperglycolysis, [26] hyperglycemia, [26] and apolipoprotein E e4 synthesis. [27] These mechanisms most likely operate in sleep disorders associated with mild head injury. MRI with tractography may provide a direct evidence of such injury. It has also been hypothesized that the hypocretin system may be partly responsible for the pathophysiology of sleep wake disturbances present post TBI [28].
Post-traumatic sleep wake disorder/s-resulting from TBI
Post-traumatic sleep/wake disorder/s resulting from neck and/or bodily injuries
Post-traumatic sleep/wake disorder/s resulting from both-TBI and neck and/or bodily injuries
Each group has 2 subtypes:
Many patients with more severe head injury initially have hypersomnia due to medications, TBI itself, complicating sleep apnea or narcolepsy but later on after several months or even years develop insomnia. Same factors as listed above operate. Reverse is also true. Patients with mild TBI may develop hypersomnia/ parasomnia or narcolepsy later on even though they had insomnia to begin with. Thus the natural history of sleep/wake disorders is more complicated than the sleep/wake disorders in general as the type of disorder may switch over time.
Although, sleep studies are not generally indicated in patients with most cases of insomnia from other etiologies, the post-traumatic insomnia requires a sleep study for many reasons. It requires documentation as the adjusters frequently look for objective confirmation of subjective symptoms. Also post-traumatic insomnia may not be just pure insomnia but contributed to by sleep apnea, narcolepsy, periodic limb movements, parasomnias such as the REM behavior disorder or a circadian rhythm disorder. In addition, the insomnia may be replaced by hypersomnia or parasomnia and/or even nocturnal seizures later on. The polysomnogram (PSG) should be done with expanded EEG montage with simultaneous video-taping. Traditional investigating methods such as sleep diary, actigraphy and scales such as Hamilton anxiety scale (HAS -appendix 3) and Beck’s depression inventory (BDI -appendix 4) also help in dissecting, intellectualizing and treating the issue at hand.
Detailed history is important. One should carefully ascertain if sleep related symptoms started after TBI or preceded that. If latter, document any changes in severity of symptoms or change in symptoms. The routine scales administered in our practice are: Mini mental state examination, ACE questionnaire, Hamilton anxiety Scale (appendix 3), Beck’s depression inventory (appendix 4), Epworth sleepiness Scale ( appendix 1) and Berlin questionnaire (appendix 2). Careful determination of LOC, PTA and GCS is done based on hospital, ER and other previous records. Computerized psychological and neuropsychological testing (easily administered by even a medical assistant using the ‘neurotrax’ system) to determine the global assessment of cognitive functioning and levels of anxiety and depression is important to establish a baseline and future follow up. Physical examination should pay careful attention to the HEENT examination, TMJ, neck size, chin (prognathia, retrognathia, micrognathia), oropharyngeal examination for tonsillar size from 1-4 and Mallampati score 1-4, focal and lateralized neurological signs and cardiopulmonary examination. Sleep/wake related history should include details about snoring, witnessed pauses in breathing, bedtime, wake up time, circadian rhythm, gasping and choking in sleep, hypnagogic hallucinations, hypnapompic hallucinations, nightmares, nocturnal incontinence, seizures, sleep walking and acting out of dreams, any falls from bed, restless legs and periodic limb movements ( by asking questions such as do you have creepy crawling sensation in your limbs and feet which improve by movement). Wakefulness should be evaluated for alertness, drowsiness, dozing, napping, daydreaming and automatic behaviors. The ESS (appendix 1) is helpful in quantitating sleepiness and Berlin questionnaire (appendix 2) about the probability of sleep related breathing disorder. Sometimes the sleepiness scales are not reliable in patients with severe head injury. Caregiver’s input is needed in those situations. Current medication list is critical.
Ancillary tests include an MRI of the head with tractography (diffuse tensor imaging or preferably constrained spherical deconvolution), EEG, an overnight in lab video-PSG with an expanded EEG montage and a 5 nap daytime multiple sleep latency test (MSLT) if ESS is greater than 10. A seven day sleep diary and actigraphy is obtained in those with insomnia or circadian rhythm issues. CSF hypocretin levels may be useful.
Initial follow up visits are monthly for 3 months and then 3 monthly times two. Six monthly visits are obtained after that. Annual ancillary evaluation is more limited and defined by patient’s clinical symptomatology. However, sleep disorders may change their characteristics during the course and re-evaluation may need to be tailored accordingly. Therefore a cook book approach is not useful. Maintenance of wakefulness test may be useful in quantitating residual daytime sleepiness.
We propose this term as an acronym for post-traumatic sleep/wake disorders to distinguish it from PTSD or post-traumatic stress disorder.
Post-traumatic sleep-related breathing disorder:
This is fairly common in general population affecting 2-4 percent of all adults. In patients with TBI, sleep apnea defined as apnea-hypopnea index (AHI) of 10 or greater may be present in up to 30 percent of all patients. Seventy five percent of apneas and hypopneas are obstructive in nature. This condition may present as hypersomnia, insomnia or may only be seen on laboratory evaluation as an unexpected finding. It may cause a secondary REM behavior disorder (RBD -a parasomnia) which may potentially be injurious to the patient if not recognized and treated and further compound the TBI. Mechanisms of post-traumatic sleep related breathing disorder are several. Patient may have pre-existing anatomical abnormalities which were insufficient to cause the sleep related breathing disorder prior to TBI but the occurrence of TBI provides a sufficient milieu for it to clinically manifest. Sedative medications such as clonazapam may potentiate apnea, antidepressants such as sertraline and mitrazepine and anticonvulsants such as valproic acid cause weight gain which is a known risk factor for this condition. Weight gain may also result from physical inactivity and direct damage to hypothalamic centers related to feeding and satiety. Tracheostomy, if done, during the acute management of TBI may further increase the risk especially in children by causing tracheomalacia, as seen in one child by the senior author of this chapter. In addition to known risks of this condition such as premature death, hypertension, heart attack, stroke, dementia and diabetes, this condition may impair the control of patient’s seizure disorder if present. Newborns with perinatal head trauma and abused children may develop central apnea due to direct injury to the breathing centers in the brain. In general, more severe the head injury, higher the apnea hypopnea index and hypoxia are. ESS (appendix 1) may be unreliable in those with moderate to severe head injury and should not be used as a sole criterion to order or not order the sleep studies. [10] Berlin questionnaire (appendix 2) also helps in predicting the probability of sleep related breathing disorder.
Post-traumatic narcolepsy:
The incidence of narcolepsy in general population is about 1:2000 in the USA. Hormonal change and minor head trauma at puberty are long known to be initiating factors for narcolepsy in neurology text books as the genetic propensity of narcolepsy usually manifests clinically at or after puberty 90 percent of the time. In addition, most patients with narcolepsy remain the same throughout their lifetime. Post-traumatic narcolepsy is different in that it is far more common than general population (it is seen in up to 6-9 percent of all patients with TBI) [10, 11] and down the road, after several years in our experience, symptoms may sometimes abate and even be replaced by insomnia. Hypocretin levels are known to be reduced by TBI and may well play a pathogenetic role. New onset cataplexy might occur after TBI, increasing the risk of falls and therefore repeated TBI. Nightmares are common in TBI and careful history is needed to distinguish them from hypnagogic and hypnapompic hallucinations seen as auxiliary symptoms of narcolepsy. Occurrence of narcolepsy is not correlated with the degree of TBI.
Polysomnogram (PSG) will nearly always show some degree of sleep disruption such as increased percentage of N1, frequent awakenings, reduced sleep efficiency (less than 85 percent), reduced N3 (delta) percentage (less than 15 percent) and sometimes SOREMP (sleep onset REM period or REM sleep occurring with 15 min of sleep onset). The MSLT will show a sleep latency of 8 min or less and 2 or more SOREMPs in 5 naps. [33]
Post-traumatic hypersomnia.
Idiopathic hypersomnolence syndrome is long known to often follow TBI and conditions such as Guillaine Barre Syndrome (GBS) or infectious mononucleosis (IM). The PSG shows relatively normal or even improved sleep efficiency sometimes greater than 95 percent, increased or normal delta percentage, relatively few awakenings, minimal sleep disruption if any but severe daytime somnolence on MSLT with no SOREMPs. Medication effect needs to be excluded and one has to be careful not to misdiagnose 15 percent cases of narcolepsy in whom MSLT is initially negative as post-traumatic hypersomnia. The PSG features described above are helpful in distinction and there is no history of hypnagogic or hypnapompic hallucinations or cataplexy. Autonomic symptoms are sometimes present. [33]
Post-traumatic periodic limb movement disorder (PLMD):
These may a solitary abnormality on PSG but more often are associated with other conditions such as OSA and narcolepsy. They may have been present premorbidly but are often worsened by medications used for the treatment of TBI. They may be asymptomatic and may not require any treatment or cause significant patient insomnia or spousal discomfort and need treatment. Lower extremities are affected and sometimes only one side but upper extremities may be involved in addition or alone. Neurologic deficit such as hemiparesis or paraparesis may worsen or cause this condition. Anemia of chronic disease may compromise the serum ferritin level and may compound the issue. They are considered significant if more than 15/hour in an adult or 5/hr in a child. [33] Up to 30 percent of all patients may have this condition. [10] They may or may not report RLS in addition when awake.
Post-traumatic REM behavior disorder (RBD):
This condition was first described to occur in cats when lesions were created in peri-locus coeruleous area to interrupt impulses going down the ventral reticulopsinal tract to spinal motor neurons in REM sleep [10]. Similar mechanisms are operative in humans with TBI. Associated Parkinson’s, alcoholism and medications may also contribute. Up to 13 percent patients show symptoms of RBD and/or show increased tone in chin EMG on PSG [10]. Patients typically act out their dreams during last third of sleep at night when REM percentage is the highest and potentially fall from bed, climb out of windows or walk out in freezing weather. It may be secondary to post-traumatic OSA and then it responds to CPAP. If not, RBD precautions and medications are necessary. It may be a precursor of Parkinsonism in patients with punch-drunk syndrome and may precede that condition by as much as 3 years. It should be distinguished from sleep walking which usually occurs during the first half of sleep and there is no dream recall. It should also be distinguished from NREM sleep related confusional arousals which are similar to night terrors.
Other post-traumatic parasomnias:
They include sleep paralysis, cataplexy, sleep walking, nightmares, sleep enuresis and nocturnal eating disorder. [33] All parasomnias (these plus RBD) occur in 25 percent of all patients with TBI, either by themselves on in addition to other disorders. Birth injuries to the head may be associated with head banging disorder. [16]
Post-traumatic insomnia:
At least one quarter of all patients with TBI have insomnia either sleep onset or sleep maintenance or a combination thereof. [10] Hamilton anxiety scores (appendix 3) are typically elevated in those with sleep onset insomnia and Beck’s depression inventory scores (appendix 4) in those with sleep maintenance insomnia. Physical factors such as frequent examination by nurses and respiratory therapists during ICU stay may be the cause at least in acute TBI. Medications such as bronchodilators, anticonvulsants such as topiramate or stimulants such as methylphenidate may cause insomnia. Circadian rhythm abnormalities and not going to regular work and physical inactivity leading to frequent daytime naps may cause insomnia at night. Post traumatic sleep related breathing disorder both of obstructive type or central type may cause insomnia as well. Severe restless leg syndrome (RLS) may cause sleep onset insomnia and PLMs, sleep maintenance insomnia. Patients with post-traumatic narcolepsy may sometimes present initially as insomnia at night and only a careful history uncovers the diagnosis. For example, a patient treated by the senior author was treated for 2 years as insomnia by various physicians, until she disclosed to the author additional history of severe daytime sleepiness and napping since TBI and disturbing “nightmares” (actually hypnagogic hallucinations) with automatic behavior which prevented her from holding onto any job and not succeed in her new marriage. She responded beautifully to sodium oxybutate and was immensely grateful.
Post-traumatic circadian rhythm disorder:
This is a fairly common complication. The disorders include a delayed sleep phase syndrome (DSPS), irregular sleep wake cycle, advanced sleep phase syndrome (ASPS) and non-24 hour sleep wake cycle. [33] Irregular sleep wake cycle is common during the acute phase of TBI in moderate to severe cases as nurses and respiratory therapists check on the patient frequently and patient is on medications including sedatives or anesthetic agents such a propofol. It is also common in chronic TBI patients with a psychiatric disorder or blindness. Otherwise DSPS is the most common complication related to circadian rhythm abnormality in patients with TBI and a direct injury to suprachiasmatic nucleus may well be the cause. ASPS is quite frequent in elderly patients with TBI. Non-24 hour cycle is a rare complication in some patients showing a stepladder pattern on actigraphy. [33]
Lack of pre-existing history of sleep related symptoms is critical for the diagnosis of the primary post-traumatic sleep disorder, although the TBI may aggravate a pre-existing sleep/wake disorder or make it more difficult to treat. Secondary gain may need to be excluded but objective confirmation from tests as outlined above, obviates that possibility. Interviewing the family members, friends, golf buddies etc and previous medical records are helpful in determining whether the disorder is primary or secondary. Previous anatomical abnormities do not automatically exclude a primary post traumatic sleep/wake disorder as patient may have been compensated before and the TBI may have been the “last straw which broke the camel’s back”. Likewise, a positive HLA testing does not automatically make narcolepsy pre-existing or genetic, as head trauma, even mild or minimal is known to be the initiating factor for narcolepsy. Please refer to the international classification of sleep disorders [33] edition 3 for further help in differential diagnosis of post-traumatic sleep disorder/s from non-traumatic etiologies as detailed discussion of that would be tangential to the intent of this chapter.
Reduction of medications may also help by reducing weight, decreasing excessive daytime sleepiness, lessening the aggravation of OSA or reducing PLMs. Some medications such as amitriptyline may induce or aggravate RBD in TBI patients and that might improve by this strategy. Sometimes, reducing topiramate, certain antidepressants, stimulants and wakefulness promoting agents etc may improve insomnia.
Patients with RBD may require padding around their beds, alarms and double locks at doors and boarding up of windows (RBD precautions). Those with nocturnal eating disorder, may need to have a lock on the refrigerator.
Ongoing follow up is essential by at least 3-6 monthly office visits and yearly sleep studies since post-traumatic sleep disorders are notorious to change during their natural history and may require altogether different treatment as the time passes by.
A spectrum of sleep disorders are a common finding after the acute phase of TBI [9]. They result in daytime somnolence which in turn may lead to poor daytime performance, altered sleep-wake schedule, heightened anxiety, and poor individual sense of well-being, insomnia and depression [10] Sleep changes and deranged sleep architecture are more common in
The future research and efforts should concentrate on primary prevention of TBI, better delineation of premorbid sleep/wake status by some scales (similar to those which predict premorbid IQ), early identification and accurate diagnosis of post-traumatic sleep/wake disorder, its exact impact on physical, cognitive and occupational rehabilitation, convincing the auto-insurances not to be stingy in the care of these unfortunate individuals and look at sleep/wake related complaints as a medical issue and not a malingering issue, and the US government to provide greater research and medical funds for this important medical condition.
0 = no chance of dozing | \n\t||
1 = slight chance of dozing | \n\t||
2 = moderate chance of dozing | \n\t||
3 = high chance of dozing | \n\t||
\n\t\t\t | \n\t\t\n\t\t\t | \n\t|
Sitting and reading | \n\t\t____________ | \n\t|
Watching TV | \n\t\t____________ | \n\t|
Sitting inactive in a public place (e.g. a theater or a meeting) | \n\t\t____________ | \n\t|
As a passenger in a car for an hour without a break | \n\t\t____________ | \n\t|
Lying down to rest in the afternoon when circumstances permit | \n\t\t____________ | \n\t|
Sitting and talking to someone | \n\t\t____________ | \n\t|
Sitting quietly after a lunch without alcohol | \n\t\t____________ | \n\t|
In a car, while stopped for a few minutes in traffic | \n\t\t____________ | \n\t
Top of Form
\n\t\t\t Height (in inches): Weight (in pounds): | \n\t\t\n\t\t\t | \n\t||
\n\t\t\t Almost every day ** 3-4 times per week ** 1-2 times per week 1-2 times per month Never or almost never | \n\t|||
\n\t\t\t | \n\t|||
\n\t\t\t Yes ** No I don\'t know | \n\t|||
8. Are you tired during waketime? Almost every day ** 3-4 times per week ** 1-2 times per week 1-2 times per month Never or almost never | \n\t|||
\n\t\t\t My snoring is as loud as breathing My snoring is as loud as talking My snoring is louder than talking ** My snoring is very loud ** | \n\t|||
4. How frequently do you snore? Almost every day ** 3-4 times per week ** 1-2 times per week 1-2 times per month Never or almost never | \n\t\t\n\t\t\t Almost every day ** 3-4 times per week ** 1-2 times per week 1-2 times per month Never or almost never | \n\t||
5. Does your snoring bother other people? Yes ** No | \n\t|||
\n\t\t\t | \n\t|||
10. Do you have high blood pressure? Yes ** No I don\'t know | \n\t|||
\n\t\t\t Almost every day ** 3-4 times per week ** 1-2 times per week 1-2 times per month Never or almost never | \n\t\tBMI (body mass index) BMI > 30 ** | \n||
Weight | \n|||
BMI = | \n\t-------------------- | \n\tX 703 | \n|
Height X Height | \n|||
Weight in pounds, height in inches OR Weight in kilograms, height in meters | \n|||
Berlin Scoring Results Any answer followed by double asterisks (**) is a positive response. Category 1 is positive with 2 or more positive responses to questions 2 through 6 Category 2 is positive with 2 or more positive responses to questions 7 through 9 Category 3 is positive with 1 or more positive responses and/or a BMI>30 2 or more positive categories indicates a high likelihood of sleep apnea | \n
Bottom of Form
1. Background | \n\t||
\n\t\t | 1. Authored by Max Hamilton in 1959 | \n\t|
\n\t\t | 2. Public domain anxiety rating scale | \n\t|
2. Symptom Rating Scale (0=Not Present, 4=Disabling) | \n\t||
\n\t\t | 1. Anxious Mood \n\t\t | \n\t|
\n\t\t | \n\t\t | 1.1. Worries | \n\t
\n\t\t | \n\t\t | 1.2. Anticipates worst | \n\t
\n\t\t | 2. Tension | \n\t|
\n\t\t | \n\t\t | 2.1.Startles | \n\t
\n\t\t | \n\t\t | 2.2. Cries easily | \n\t
\n\t\t | \n\t\t | 2.3. Restless | \n\t
\n\t\t | \n\t\t | 2.4. Trembling | \n\t
\n\t\t | 3. Fears | \n\t|
\n\t\t | \n\t\t | 3.1. Fear of the dark | \n\t
\n\t\t | \n\t\t | 3.2. Fear of strangers | \n\t
\n\t\t | \n\t\t | 3.3. Fear of being alone | \n\t
\n\t\t | \n\t\t | 3.4. Fear of animal | \n\t
\n\t\t | 4. Insomnia \n\t\t | \n\t|
\n\t\t | \n\t\t | 4.1. Difficulty falling asleep or staying asleep | \n\t
4.2. Difficulty with Nightmares | \n\t||
\n\t\t | 5. Intellectual | \n\t|
\n\t\t | \n\t\t | 5.1. Poor concentration | \n\t
\n\t\t | \n\t\t | 5.2. Memory Impairment | \n\t
\n\t\t | 6. Depressed Mood | \n\t|
\n\t\t | \n\t\t | 6.1. Decreased interest in activities | \n\t
\n\t\t | \n\t\t | 6.2. Anhedonia | \n\t
\n\t\t | \n\t\t | 6.3. Insomnia | \n\t
\n\t\t | 7. Somatic Complaints: Muscular | \n\t|
\n\t\t | \n\t\t | 7.1. Muscle aches or pains | \n\t
\n\t\t | \n\t\t | 7.2. Bruxism | \n\t
\n\t\t | 8. Somatic Complaints: Sensory | \n\t|
\n\t\t | \n\t\t | 8.1. Tinnitus | \n\t
\n\t\t | \n\t\t | 8.2. Blurred vision | \n\t
\n\t\t | 9. Cardiovascular Symptoms | \n\t|
\n\t\t | \n\t\t | 9.1. Tachycardia | \n\t
\n\t\t | \n\t\t | 9.2. Palpitations | \n\t
\n\t\t | \n\t\t | 9.3. Chest Pain | \n\t
\n\t\t | \n\t\t | 9.4. Sensation of feeling faint | \n\t
\n\t\t | 10. Respiratory Symptoms | \n\t|
\n\t\t | \n\t\t | 10.1. Chest pressure | \n\t
\n\t\t | \n\t\t | 10.2. Choking sensation | \n\t
\n\t\t | \n\t\t | 10.3. Shortness of Breath | \n\t
\n\t\t | 11. Gastrointestinal symptoms | \n\t|
\n\t\t | \n\t\t | 11.1. Dysphagia | \n\t
\n\t\t | \n\t\t | 11.2. Nausea or Vomiting | \n\t
\n\t\t | \n\t\t | 11.3. Constipation | \n\t
\n\t\t | \n\t\t | 11.4. Weight loss | \n\t
\n\t\t | \n\t\t | 11.5. Abdominal fullness | \n\t
\n\t\t | 12. Genitourinary symptoms | \n\t|
\n\t\t | \n\t\t | 12.1. Urinary frequency or urgency | \n\t
\n\t\t | \n\t\t | 12.2. Dysmenorrhea | \n\t
\n\t\t | \n\t\t | 12.3. Impotence | \n\t
\n\t\t | 13. Autonomic Symptoms | \n\t|
\n\t\t | \n\t\t | 13.1. Dry Mouth | \n\t
\n\t\t | \n\t\t | 13.2. Flushing | \n\t
\n\t\t | \n\t\t | 13.3. Pallor | \n\t
\n\t\t | \n\t\t | 13.4. Sweating | \n\t
\n\t\t | 14. Behavior at Interview | \n\t|
\n\t\t | \n\t\t | 14.1. Fidgets | \n\t
14.2. Tremor | \n\t||
14.3. Paces | \n\t||
3. Interpretation | \n\t||
\n\t\t | 1. Above 14 symptoms are graded on scale | \n\t|
\n\t\t | \n\t\t | 1.1. Not present: 0 | \n\t
\n\t\t | \n\t\t | 1.2. Very severe symptoms: 4 | \n\t
\n\t\t | 2. Criteria | \n\t|
\n\t\t | \n\t\t | 2.1. Mild Anxiety (minimum for Anxiolytic): 18 | \n\t
\n\t\t | \n\t\t | 2.2. Moderate Anxiety: 25 | \n\t
\n\t\t | \n\t\t | 2.3. Severe Anxiety: 30 | \n\t
4. Other Anxiety Scales | \n\t||
\n\t\t | 1. Zung Self Rating Scale for Anxiety | \n\t|
\n\t\t | 2. Beck Anxiety Scale | \n\t|
\n\t\t | 3. GAD-7 | \n\t
1. Background | \n\t||
\n\t\t | 1. Twenty-one question survey completed by patient | \n\t|
\n\t\t | 2. Answers scored on 0 to 3 scale | \n\t|
\n\t\t | \n\t\t | 1.1. Minimal: 0 | \n\t
\n\t\t | \n\t\t | 1.2. Severe: 3 | \n\t
2. Questions | \n\t||
\n\t\t | 1. Sadness | \n\t|
\n\t\t | 2. Hopelessness | \n\t|
\n\t\t | 3. Past failure | \n\t|
\n\t\t | 4. Anhedonia | \n\t|
\n\t\t | 5. Guilt | \n\t|
\n\t\t | 6. Punishment | \n\t|
\n\t\t | 7. Self-dislike | \n\t|
\n\t\t | 8. Self-blame | \n\t|
\n\t\t | 9. Suicidal thoughts | \n\t|
\n\t\t | 10. Crying | \n\t|
\n\t\t | 11. Agitation | \n\t|
\n\t\t | 12. Loss of interest in activities | \n\t|
\n\t\t | 13. Indecisiveness | \n\t|
\n\t\t | 14. Worthlessness | \n\t|
\n\t\t | 15. Loss of energy | \n\t|
\n\t\t | 16. Insomnia | \n\t|
\n\t\t | 17. Irritability | \n\t|
\n\t\t | 18. Decreased appetite | \n\t|
\n\t\t | 19. Diminished concentration | \n\t|
\n\t\t | 20. Fatigue | \n\t|
\n\t\t | 21. Lack of interest in sex | \n\t|
3. Interpretation | \n\t||
\n\t\t | 1. Score <15: Mild Depression | \n\t|
\n\t\t | 2. Score 15-30: Moderate Depression | \n\t|
\n\t\t | 3. Score >30: Severe Depression | \n|
Resources: Beck Depression Inventory | \n||
\n\t | 1. General | \n|
\n\t | \n\t | 1.1. Intended for use by licensed professionals only | \n
\n\t | \n\t | 1.2. Copyrighted by the Psychological Corporation | \n
\n\t | 2. Available for purchase from Psychological Corporation | \n|
\n\t | \n\t | 2.1. http://www.psychcorp.com/ | \n
5. Reference | \n||
\n\t | 1. Beck (1996) Beck Depression Inventory, Harcour | \n
Wake up and go to bed at about the same time every night. Bedtime and wake-up time should not differ from working days to weekend nights by more than approximately an hour.
Avoid sleeping in on weekends to “catch up” on sleep. This makes it more likely that you will have problems falling asleep.
If you take naps, they should be short (no more than an hour) and scheduled in the early to midafternoon. However, if you have a problem with falling asleep at night, napping during the day may make it worse and should be avoided.
Spend time outside every day. Exposure to sunlight helps to keep your body\'s internal clock on track.
Exercise regularly. Exercise may help you fall asleep and sleep more deeply.
Use your bed for sleeping only. Don\'t study, read, listen to music, watch television, etc., on your bed.
Make the 30–60 minutes before a quiet or wind-down time. Relaxing, calm, enjoyable activities, such as reading a book or listening to calm music, help your body and mind slow down enough to let you get to sleep. Don\'t study, watch exciting/scary movies, exercise, or get involved in “energizing” activities just before bed.
Eat regular meals and don\'t go to bed hungry. A light snack before bed is a good idea; eating a full meal in the hour before bed is not.
Avoid eating or drinking products containing caffeine from dinner time on. These include caffeinated sodas, coffee, tea, and chocolate.
Do not use alcohol. Alcohol disrupts sleep and may cause you to awaken throughout the night.
Smoking disturbs sleep. Don\'t smoke at least one hour before bed (and preferably, not at all!).
Go to bed when sleepy.
Use the bed for sleeping; do not read, watch television or eat in bed.
If you are unable to fall asleep, get up and move to another room; stay up until you are really sleepy, then return to bed; if sleep still does not come easily, get out of bed again. The goal is to associate bed with falling asleep quickly.
Repeat step 3 as necessary throughout the night.
Set the alarm and get up at the same time every morning regardless of how much you slept through the night. This helps the body acquire a constant sleep-wake rhythm.
Do NOT nap during the day.
Sleep restriction or curtailment
Relaxation, meditation, hypnosis
Reducing muscle tension and hyperarousal by biofeedback
Don\'t compensate for sleep loss
Start stimulus control procedures immediately
Re-engage sleep restriction should the insomnia persist beyond a few days.
Starch is one of the major constituents of reserve food material, which serves as fuel for the human body. The calorific value of starch is 17.5 kJ/g, which is not only responsible for most of the metabolic functions but also acts as a crucial regulatory adjunct to control energy balance. Starch existed as the major dietary nutrient since time immemorial but the dietary transition with enriched refined products as well as carbaholic staples led to the unprecedented increase in the pre-diabetic and diabetic population with characteristic chronic hyperglycemia. Hence glycaemic response (GR) eliciting potential of food known as the glycemic index (GI) or glycemic potential (GP) are major aspects to understand as well as to fine-tune. In a food matrix, starch bioavailability is modulated by the microstructure (cell wall, membrane, cell layers, granular size, etc.) as well as its dense composition (macro and micronutrients) [1]. Based on the interacting components food matrix interactions are classified as binary (two-component), ternary (three-component), and quaternary (four-component) [2, 3, 4, 5, 6]. Types of binary interactions and their effect on starch bioavailability are depicted in Figure 1.
Types of binary interactions and its effect on starch bioavailability. Binary interactions modulate physiochemical, structural, and biological attributes limiting starch digestibility as well as ultimate glycemic response.
Among these, a binary component has gained great importance and has been extensively characterized by component depletion or addition studies under in-vitro conditions [7, 8]. The observed low GP of whole grain foods like millets, pigmented rice has been well correlated with such matrix interactions present endogenously, while high GI has also been reported to lower by exogenous addition of such matrix components [9, 10, 11]. The state and types of matrix component (lipid/protein/fiber) which interacts at various scales have also been known to alter the starch micro configuration (repeat, reconstruct the sentence limiting the digestibility, result in lowering the glycemic response [9, 12].
Binary interactions have been majorly characterized using nutrient-sensing fluorescent probe-based confocal laser scanning microscopy (CLSM), where the proximity as well as encapsulating effect of matrix components limiting the starch hydrolytic metabolic enzymes have been observed [13, 14]. Further, the effect of such interactions on starch functional aspects like hydration, enzymatic cleavage, or enthalpy have been delineated using differential scanning calorimetry (DSC). Scanning electron microscopy (SEM) assisted in revealing the structural alterations associated with starch in the matrix after component depletion or addition. Rapid visco analysis (RVA) revealed that viscosity and pasting parameters were found inversely associated with in-vitro starch digestibility. The effect of matrix components in retaining the matrix, granule stability, preventing the expansion of granules as well as limiting the glycolytic enzyme attack has been endorsed using this technique [15, 16]. Other than affecting the swelling of starch granules by reducing the contact with carbolytic enzymes, the effect of such binary interactions in altering the molecular configuration (digestion sensitive A or B type to resistant V-type) of starch was envisioned and characterized using X-ray diffraction (XRD) and Fourier transform infrared microscope (FTIR).
Among the binary interactions, the most relevant in limiting the glycemic amplitude includes starch-lipid, starch-protein & starch-fiber dynamics.
Even though well compartmentalized, starch and lipids do interact endogenously in real food systems. Lipid content ranges from 0.2–7% in cereals, with the least reported in rice and maximum reported in the case of oats & pearl millet [17]. A balanced distribution of neutral, glycol, and phospholipids along with free fatty acids have been reported in most of the food matrices, assist in energy as well as membrane structure & functions [17]. Curiosity towards food matrix interactions underlined a striking correlation between high lipid content [18] and low GR, which initiated binary (starch-lipid) interaction studies [7, 8]. Endogenous and exogenous lipid content have found to have low in-vitro starch digestibility along with superior resistant starch (RS) fraction. The effect of endogenous and exogenous lipid types have recently shown to have an effect in increasing starch-lipid complexation enriching RS content in red rice [9, 10]. Ye et al. [11] suggested that among lipids and proteins, starch digestibility is most affected by lipids as it affects swelling of granules, reduces the contact with carbolytic enzymes as well as alters the molecular structure from A-type into resistant V-type pattern. The long hydrophobic tail of lipid entering the cavity-like structure of amylose enables starch to form a stable complex, thereby hindering the accessibility of starch to enzyme attack [11]. In the case of mung bean flour, in-vitro starch digestibility and GI were increased significantly when endogenous lipids were removed [19]. Previous studies by Panyoo et al. [12], Krishnan et al. [9] have mentioned that stable starch-lipid complex results in a twist in digestibility phenotype into a digestion resistant fraction (RS-V), which caters to the gut microflora. As stated above, Copeland et al. [20]; Wang and Copeland [21] suggested this inclusion complex of starch-lipid also has an immense role in the food industry such as lowering solubility, swelling power, starch gelatinization, retrogradation, and enzyme action.
Starch-lipid complexes can exist inherently within the food matrix, or they may be produced by exogenous applications. A study by Obiro et al. [22]; reported that this complexation is mainly influenced by non-covalent interactions (hydrogen bonds, hydrophobic interactions, van der Waals interactions, and so on). Hydroxyl groups α-(1,4) are situated on the outer surface whereas methylene and oxygen groups present in the inner region of the complex strengthen the formation of starch-lipid complexes. Considering all positive impacts of starch-lipid complex, there are few factors (chain length of amylose, amylopectin, fatty acids, degree of unsaturation) that mostly govern the degree of complexation [10]. Various researchers stated that amylose acts as the primary constituent to interact with lipid molecules, while few reports supported the role of amylopectin chain length to form the complex [23, 24]. It has been reported from various studies that starch-lipid complexability has been increased with the longer chain length/degree of polymerization (DP) which highlights the formation of crystalline structure [25]. In addition to the effect exerted by the chain length of starch components, processing conditions like cooking also affect starch-lipid interaction. Kaur et al. [8] suggested amylose-lipid complexation enhanced with amylose chain length and increased with cooking time. Experiments highlighted the stability of starch-lipid inclusion complex formation mainly based on the types of fatty acids accommodated inside the helical cavity [26]. Different reports exist on the type of fatty acid for stable starch-lipid complexation. One school of thought suggests that the stability of the S-L complex could be enhanced by increasing the aliphatic chain length of fatty acids as well as melting temperature (from 8–10). On the other hand, another dimension highlights that smaller carbon chain length fatty acids might be more soluble into the aqueous solution and less stable also [27, 28]. Tufvesson et al. reported C14 as the most stable conformation than C16 or C18 while other explained C16 or C18 is better in the case of complexability [28]. Therefore, saturated fatty acid (SFA) with increased chain length can easily form a stable complex which further affects enzymatic accessibility due to resistance against carbolytic enzymes. Studies over decades highlighted that only SFA can be able to form a strong stable S-L complex with increasing chain length in a temperature-dependent manner whereas an inverse relationship has been found for unsaturated fatty acid (UFA) [26, 28]. A report from Zheng et al. [29] stated that chain length and degree of unsaturation have a role in the compact structure of starch-lipid formation. In addition to this, Kawai et al. [30] & Meng et al. [31] revealed starch-UFA complex showed resistance by formatting a stable complex to digestive enzyme action. The degree of complexability of FA in the case of maize starch ranged from 11.60–26.31% according to Sun et al. report [32]. Moreover, it has been explained from Sun et al. [32] RS is also enriched with the degree of unsaturation from 0 to 2%. In addition, thermal properties are also greatly affected by this S-L complex. Thermal complexes are mainly classified into two types of complexes as type I (90–115°C), type II (115–130°C) depending on the melting temperature. Studies from previous research have already highlighted that developed type II complex is more resistant to the digestive enzymes as compared to type I complex [33]. But Sun et al. [32] unraveled that maize starch-linoleic acid (MS-LOA) primarily formed as type I complex while maize starch-stearic acid (MS-SA) belonged to type I & type II complex. The reason behind this could be the large steric hindrance associated with LOA than SA which showed less accessibility of enzymes and inhibits ultimate glucose release. Cheng et al. [34] also used molecular dynamics to study amylose and linoleic acid structural analysis and conformational changes during complexation. On the continuation with Cheng et al., recently another research group of Schahl et al. [35] revealed the molecular structural complex using 13 NMR spectroscopy where they have taken quantum DFT approach affected by amylose size fragment and specific intramolecular hydrogen bonds. Hence, all the V-type complexes produced due to the addition of lipids act as a stable resistant structure against all digestive enzymes which further lowers glycemic response.
Proteins, mostly in the form of amino acids, and enzymes, are the predominant component in the food matrix, other than starch and fat [36]. Apart from the nutritional quality, proteins act as the major microstructural framework in a food matrix and hence also act as a physical barrier towards starch hydrolysis [37]. An interesting correlation among the reduction in insulinemic and glycemic responses by increasing the protein content in starchy crops led to the possibility of starch-protein interplay. Among the protein types, albumin, glutenins, and globulins aid in the gluing of protein bodies into a matrix enveloping the starch granules, which act as a barrier for starch digestion [38]. The existence of a protein barrier encircling the starch granule was validated using the pronase enzyme which dissociates the protein matrix and results in a considerable increase in-vitro starch digestibility [39]. Annor et al. [40] reported that the hypoglycemic characteristic of Kodo millet was related to the protein encircling the starch granules. Ren et al. [41] also reported that there was a fast increment in in-vivo GI and in-vitro starch digestibility of foxtail millet flour due to the lack of starch-protein complex after deproteination. Various studies have reported that the presence of gluten has an impact on the pace of starch digestion, resulting in reduced glycemic response [42, 43]. Gluten develops a visco-elastic and thick network that entraps starch granules, as well as a compact and stable structure that prevents starch granules from expanding and leaching during cooking, resulting in reduced accessibility of enzyme and slow-release properties [44]. To study the impact of protein removal from wheat products (bread) on blood glucose, healthy individuals were given meals of white bread prepared either from normal or gluten-free flour. It was observed that there was a considerable increase in blood glucose after consuming bread prepared from gluten-free flour. This led to an increase in digestion rate in-vitro and declined the starch mal-absorption in vivo as studied via breath-H2 measurements, but this impact was not restored when the gluten was later added back to the gluten-free flour. The possible mechanism behind this may be all-purpose wheat flour is made up of granules with a starch core enveloped by a protein network that inhibits the hydrolysis rate in the small intestine lumen [45]. Recently, Lu et al. [46] revealed that in the small intestine, amino acids generated from enzymatic hydrolysis of rice protein inhibited the porcine pancreatic α-amylase activity. The protein content of rice flour was shown to be negatively associated with rapidly digestible starch (RDS) and slowly digestible starch (SDS), while positively with RS [47], on the other hand, the total protein content of rice grain was found to be inversely correlated with in-vivo GI [48].
Other than endogenous factors, processing (thermic/mechanical) has been found to have an effect in altering the level of interaction between protein-starch molecules, influencing the overall digestibility [49]. Pasini et al. [50] found that in-vitro digestion of wheat protein has been considerably reduced at elevated cooking temperatures (>180°C) due to the development of high molecular weight protein aggregates which are stabilized by strong irreversible linkages, distinct from hydrophobic and/or disulfide bonds that could be prevalent at low temperatures (100°C). Furthermore, it has been found that “appropriate” kneading/mixing promotes the development of a protein matrix (gluten) via disulfide linkages. Moreover, if extreme kneading/mixing is performed, the matrix loses strength as the linkages break and glutenin particles are fragmented into smaller fragments, which helps digestive enzymes access the starch and thus increases the starch digestibility [51].
Protein-enriched food formulations have also been found to impact the overall GI and thus assist in developing diabetic-friendly foods. Formulations based on proso millet starch and different protein mixtures (15% zein + 10% whey protein isolate + 15% soy protein isolate) reported that protein types reduced the RDS levels and enhanced RS levels from 4.49% to 11.73%. The blend comprising of corn starch (10%) and whey protein isolate had a considerably higher concentration of RS and low RDS as compared to pure corn starch. This could be due to the increased protein matrix enveloping starch networks, preventing amylolytic attack. When soy protein was added to maize starch, RDS was reduced while SDS and RS were increased [52]. The addition of 51% rice protein in wheat starch along with cellulose reduced RDS level, whereas the addition of protein from pea proteins (82%), maize (95%), soy (94%), and wheat (86%) did not affect RDS levels [13]. Bio-mimicking interactions in corn grains using microencapsulation of corn starch by zein protein have been reported with lowered starch digestibility [53]. Furthermore, starch coupled with amino acids or protein via the Maillard process has been demonstrated to limit the starch swelling, solubility as well as digestion rate [54], however, potential negative effects due to glycated product consumption must be examined in detail [55].
Dietary fiber (DF), which consists primarily of non-starch polysaccharides found in plant cell walls, is an essential part of the food matrix [56]. DF types present in any food matrix are classified based on their water solubility and fermentability. Lignin, cellulose, and hemicelluloses are the major water-insoluble DF that get less fermented while the water-soluble DF includes pectin, mucilage, and gums and gets fermented properly in the small intestine [57]. Among the types, insoluble DF has been reported to be more useful in decreasing the GI as compared to their soluble fraction [58] as most of the common cereals contained a low level of naturally occurring soluble DF [59]. The endogenous fibers encircle the starch granules forming a starch-fiber network in the matrix, bio-mimicking an intact microstructure (plant cell/tissue) result in reduced enzyme accessibility and altered digestibility. Dense matrix composition in fiber content has been positively correlated to minimal postprandial GR after consumption in the case of barley, wheat, psyllium husk, and oats. This has been majorly attributed to the effect of insoluble DF in reducing starch bio accessibility as well as bioavailability [60, 61]. On the other hand, soluble DF like inulin has been found to form a protective barrier surrounding the starch granules, reducing starch swelling and release of amylose thus resulting in low viscosity values. This reduced the accessibility of starch-degrading enzymes that affect the in vivo starch digestibility and GI [62]. Among the studied types, β-glucan and guar gum have been reported to reduce the enzyme diffusion kinetics and thus the rate of carbohydrate digestion, eventually resulting in to slow down the gastric emptying and lower the liberation and absorption of glucose in the small intestine [63, 64]. The endogenous presence of β-glucans (native-form) in oats have been found to have an enveloping role towards starch and protein, thus reducing the enzyme accessibility, in turn, lowered starch digestibility and postprandial glycemia [65].
Endogenous presence, as well as exogenous addition of cellulose (insoluble fiber), has considerably reduced the α-amylase activity via mixed-type inhibition resulting in lowered in-vitro starch digestion [66]. The reduction of α-amylase activity was found to be positively linked with cellulose content, and α-amylase was found to be non-specifically linked on the surface of cellulose, reducing starch hydrolysis. Interaction study between pectin and digestive enzyme (amyloglucosidase) showed a similar pattern, where pectin resulted in the conformational alteration in an enzyme that impeded substrate access and slower digestion rate of long amylopectin chains [67]. Luo and Zhang [68] aimed to mimic the microstructure of endosperm tissue by constructing a starch in a whole-grain-like structural form using calcium-induced alginate gelation in the presence of β-glucan and starch.
Processing strategies, as well as formulations with exogenous addition of fiber types, have also been found to reduce the in-vitro starch digestibility and GI of foods [69]. The addition of fibers like xanthan gum, glucomannan, and agar in rice lowered the starch digestibility in-vitro and in-vivo [70, 71]. However, no relationship was observed between native fiber content (0.5%) and in-vivo starch digestibility in rice, even though the fiber level was certainly too less to have any influence on starch digestion [48]. Reduction in blood glucose [72] and in-vitro starch digestibility [73] was observed in wheat products after adding β-glucan. β-Glucan has been assumed to improve viscosity, which could have lowered the rate of gastric emptying [72] and lowered the rate of diffusion of starch digestive enzymes. Vegetables like
In this direction, several animal studies have been carried out to study the effect of adding fiber on starch bioavailability or glucose release. The supplement of insoluble cereal DF from oat leads to enhanced insulin sensitivity in obese mice [80]. Further studies conducted by Weickert et al. [81] revealed that oat DF and purified wheat can enhance the postprandial insulin secretion hormones which further improved the postprandial carbohydrate metabolism. The high level (500 mg/kg body weight) of oat β-glucan or 4% barley β-glucan resulted in considerable enhancement of insulin resistance in insulin-resistant mice model and the impact was concentration-dependent [82, 83]. β-Glucan was found to inhibit the intestinal disaccharides’ activities in-vitro and in-vivo, which led to slow starch digestion rate [84]. In the diabetic mice model, β-glucan considerably repaired and increased the integrity of pancreatic islet β-cell and tissue structures [85]. Overall, the type and concentration of fiber have a customized effect on the food matrix. Comprehensive list of various food components added to starch and their effect on starch digestibility is tabulated in Table 1.
S. no. | Food component added | Added to starch | Impact on starch digestibility | Reference |
---|---|---|---|---|
1. | Cooking fats (ghee, coconut oil, virgin coconut oil, rice bran oil) (2.5%) | Rice starch (white, black, red) | [9] | |
2. | Linoleic acid (0.75%) | Arrowhead tubers starch | [86] | |
3. | Ascorbyl palmitate (10%) | High amylose maize starch, potato starch | [87] | |
4. | Trans-oleic acid, cis-oleic acid, cis linoleic acid (1%, 3%, 5%) | Rice starch | [87] | |
5. | Palmitic acid (0.5%) | Waxy rice starch | [88] | |
6. | Oleic acid (1%, 2%, 3%) & linoleic acid (2%, 4%, 6%) | Rice starch | [89] | |
7. | Linoleic acid, monomyristyl glycerol (0%, 0.5%, 1%, 1.5%, 2%, 3%, 5%) | Maize starch | [90] | |
8. | Oleic acid (4%) | Native rice starch | [91] | |
9. | Palm oil (5%, 10%) | Arrowroot starches | [92] | |
10. | Lauric acid (1.5%) | Wheat starch | [93] | |
11. | Oleic acid (0.05%) | Native potato starch | [94] | |
12. | Dodecanoic acid, tetradecanoic acid, octadecanoic acid (1%, 3%, 5%) | Native rice starch | [95] | |
13. | Decanoic acid, palmitic acid (10%) | Native maize starch | [32] | |
14. | Lauric acid, stearic acid and glycerides (glycerol monolaurate, glycerol monostearate) (0.18%) | Wheat starch | [93] | |
15. | Palmitic acid (0.3%) | Maize starch | [1] | |
16. | Rice globulin (2%) | Rice starch | [15] | |
17. | Common bean (15%, 30%, 45%) | Wheat semolina | [96] | |
18. | Gluten (2%) | Wheat flour | [97] | |
19. | Beans (10%, 20%, 30%) | Semolina flour | [98] | |
20. | White beans (15%, 30%, 45%) | Rice flour | [99] | |
21. | Rice protein (51%) | Wheat starch | [52] | |
22. | Alfalfa seed (15%, 30%, 45%) | Rice flour | [100] | |
23. | Hydrolyzed protein (12%) | Wheat flour | [13] | |
24. | Gluten (20%) | Wheat starch | [101] | |
25. | Whey protein isolate (2.5%, 4.5%, 10%) | Native corn starch | [102] | |
26. | Rice globulin (2.5%) | Rice flour | No effect on digestibility | [103] |
27. | Soybean peptide (5%, 10%, 15%) | Corn or potato starch | [104] | |
28. | Chickpea protein (8%) | Rice flour | [105] | |
29. | Oat fiber (10%) | GF bread | [70] | |
30. | Oat fiber (>5%) | Pasta | [106] | |
31. | Inulin (12%) | GF bread | [107] | |
32. | Cellulose (50%) | Potato starch | [79] | |
33. | Cellulose (9–83%) | Maize starch | [66] | |
34. | Wheat flour | [73] | ||
35. | Glucomannan (0.1–0.2%) | Rice starch | [70] | |
36. | Xanthun gum (0.4%) | Rice starch | [71] | |
37. | RSIV (Novelose 480) (10%) | Pasta | [108] | |
38. | RSIV (Novelose 480) (10%) | GF bread | [69] | |
39. | RSII (Native HA maize starch) (20%) | GF bread | [109] | |
40. | RSII (Hi-maizeTm 260) (20%) | Pasta | [106] | |
41. | RSII (FibersymTm70) (20%) | Pasta | [77] | |
42. | Okara (10%) | Rice noodles | [74] |
List of various food components added to starch and their effect on starch digestibility.
Binary interactions among the nutrient types and starch mediate the glycemic amplitude of real food systems. Among the binary interactions (starch-lipid, starch-protein, starch-fiber), the role has been extensively characterized in limiting the enzyme penetrance, altering the molecular configuration, starch digestibility, and thus in turn GR. Understanding such binary interactions, not only shares a logical explanation for the low GI of whole-grain foods but also the immense role of such cereals in diabetic-friendly foods. Even though the existing rationale supports the fact that multiple food matrix interaction studies at a time are difficult, it’s indeed vital to study ternary (three-way) and quaternary (four-way) interactions and their role in limiting the glycemic response. Finally, it’s important to keep in mind that altering starch’s nutritional qualities can also change its desired physicochemical and sensory qualities, affecting food quality that should be considered while developing novel foods.
The authors declare no conflict of interest.
IntechOpen - where academia and industry create content with global impact
",metaTitle:"Team",metaDescription:"Advancing discovery in Open Access for the scientists by the scientist",metaKeywords:null,canonicalURL:"page/team",contentRaw:'[{"type":"htmlEditorComponent","content":"Our business values are based on those any scientist applies to their research. We have created a culture of respect and collaboration within a relaxed, friendly and progressive atmosphere, while maintaining academic rigour.
\\n\\nCo-founded by Alex Lazinica and Vedran Kordic: “We are passionate about the advancement of science. As Ph.D. researchers in Vienna, we found it difficult to access the scholarly research we needed. We created IntechOpen with the specific aim of putting the academic needs of the global research community before the business interests of publishers. Our Team is now a global one and includes highly-renowned scientists and publishers, as well as experts in disseminating your research.”
\\n\\nBut, one thing we have in common is -- we are all scientists at heart!
\\n\\nSara Uhac, COO
\\n\\nSara Uhac was appointed Managing Director of IntechOpen at the beginning of 2014. She directs and controls the company’s operations. Sara joined IntechOpen in 2010 as Head of Journal Publishing, a new strategically underdeveloped department at that time. After obtaining a Master's degree in Media Management, she completed her Ph.D. at the University of Lugano, Switzerland. She holds a BA in Financial Market Management from the Bocconi University in Milan, Italy, where she started her career in the American publishing house Condé Nast and further collaborated with the UK-based publishing company Time Out. Sara was awarded a professional degree in Publishing from Yale University (2012). She is a member of the professional branch association of "Publishers, Designers and Graphic Artists" at the Croatian Chamber of Commerce.
\\n\\nAdrian Assad De Marco
\\n\\nAdrian Assad De Marco joined the company as a Director in 2017. With his extensive experience in management, acquired while working for regional and global leaders, he took over direction and control of all the company's publishing processes. Adrian holds a degree in Economy and Management from the University of Zagreb, School of Economics, Croatia. A former sportsman, he continually strives to develop his skills through professional courses and specializations such as NLP (Neuro-linguistic programming).
\\n\\nDr Alex Lazinica
\\n\\nAlex Lazinica is co-founder and Board member of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his Ph.D. in Robotics at the Vienna University of Technology. There, he worked as a robotics researcher with the university's Intelligent Manufacturing Systems Group, as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and, most importantly, co-founded and built the International Journal of Advanced Robotic Systems, the world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career since it proved to be the pathway to the foundation of IntechOpen with its focus on addressing academic researchers’ needs. Alex personifies many of IntechOpen´s key values, including the commitment to developing mutual trust, openness, and a spirit of entrepreneurialism. Today, his focus is on defining the growth and development strategy for the company.
\\n"}]'},components:[{type:"htmlEditorComponent",content:"Our business values are based on those any scientist applies to their research. We have created a culture of respect and collaboration within a relaxed, friendly and progressive atmosphere, while maintaining academic rigour.
\n\nCo-founded by Alex Lazinica and Vedran Kordic: “We are passionate about the advancement of science. As Ph.D. researchers in Vienna, we found it difficult to access the scholarly research we needed. We created IntechOpen with the specific aim of putting the academic needs of the global research community before the business interests of publishers. Our Team is now a global one and includes highly-renowned scientists and publishers, as well as experts in disseminating your research.”
\n\nBut, one thing we have in common is -- we are all scientists at heart!
\n\nSara Uhac, COO
\n\nSara Uhac was appointed Managing Director of IntechOpen at the beginning of 2014. She directs and controls the company’s operations. Sara joined IntechOpen in 2010 as Head of Journal Publishing, a new strategically underdeveloped department at that time. After obtaining a Master's degree in Media Management, she completed her Ph.D. at the University of Lugano, Switzerland. She holds a BA in Financial Market Management from the Bocconi University in Milan, Italy, where she started her career in the American publishing house Condé Nast and further collaborated with the UK-based publishing company Time Out. Sara was awarded a professional degree in Publishing from Yale University (2012). She is a member of the professional branch association of "Publishers, Designers and Graphic Artists" at the Croatian Chamber of Commerce.
\n\nAdrian Assad De Marco
\n\nAdrian Assad De Marco joined the company as a Director in 2017. With his extensive experience in management, acquired while working for regional and global leaders, he took over direction and control of all the company's publishing processes. Adrian holds a degree in Economy and Management from the University of Zagreb, School of Economics, Croatia. A former sportsman, he continually strives to develop his skills through professional courses and specializations such as NLP (Neuro-linguistic programming).
\n\nDr Alex Lazinica
\n\nAlex Lazinica is co-founder and Board member of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his Ph.D. in Robotics at the Vienna University of Technology. There, he worked as a robotics researcher with the university's Intelligent Manufacturing Systems Group, as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and, most importantly, co-founded and built the International Journal of Advanced Robotic Systems, the world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career since it proved to be the pathway to the foundation of IntechOpen with its focus on addressing academic researchers’ needs. Alex personifies many of IntechOpen´s key values, including the commitment to developing mutual trust, openness, and a spirit of entrepreneurialism. Today, his focus is on defining the growth and development strategy for the company.
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"58592",title:"Dr.",name:"Arun",middleName:null,surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/58592/images/1664_n.jpg",biography:"Arun K. Shanker is serving as a Principal Scientist (Plant Physiology) with the Indian Council of Agricultural Research (ICAR) at the Central Research Institute for Dryland Agriculture in Hyderabad, India. He is working with the ICAR as a full time researcher since 1993 and has since earned his Advanced degree in Crop Physiology while in service. He has been awarded the prestigious Member of the Royal Society of Chemistry (MRSC), by the Royal Society of Chemistry, London in 2015. Presently he is working on systems biology approach to study the mechanism of abiotic stress tolerance in crops. His main focus now is to unravel the mechanism of drought and heat stress response in plants to tackle climate change related threats in agriculture.",institutionString:null,institution:{name:"Indian Council of Agricultural Research",country:{name:"India"}}},{id:"4782",title:"Prof.",name:"Bishnu",middleName:"P",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/4782/images/system/4782.jpg",biography:"Bishnu P. Pal is Professor of Physics at Mahindra École\nCentrale Hyderabad India since July 1st 2014 after retirement\nas Professor of Physics from IIT Delhi; Ph.D.’1975 from IIT\nDelhi; Fellow of OSA and SPIE; Senior Member IEEE;\nHonorary Foreign Member Royal Norwegian Society for\nScience and Arts; Member OSA Board of Directors (2009-\n11); Distinguished Lecturer IEEE Photonics Society (2005-\n07).",institutionString:null,institution:{name:"Indian Institute of Technology Delhi",country:{name:"India"}}},{id:"69653",title:"Dr.",name:"Chusak",middleName:null,surname:"Limsakul",slug:"chusak-limsakul",fullName:"Chusak Limsakul",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Prince of Songkla University",country:{name:"Thailand"}}},{id:"23804",title:"Dr.",name:"Hamzah",middleName:null,surname:"Arof",slug:"hamzah-arof",fullName:"Hamzah Arof",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/23804/images/5492_n.jpg",biography:"Hamzah Arof received his BSc from Michigan State University, and PhD from the University of Wales. Both degrees were in electrical engineering. His current research interests include signal processing and photonics. Currently he is affiliated with the Department of Electrical Engineering, University of Malaya, Malaysia.",institutionString:null,institution:{name:"University of Malaya",country:{name:"Malaysia"}}},{id:"41989",title:"Prof.",name:"He",middleName:null,surname:"Tian",slug:"he-tian",fullName:"He Tian",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"East China University of Science and Technology",country:{name:"China"}}},{id:"33351",title:null,name:"Hendra",middleName:null,surname:"Hermawan",slug:"hendra-hermawan",fullName:"Hendra Hermawan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/33351/images/168_n.jpg",biography:null,institutionString:null,institution:{name:"Institut Teknologi Bandung",country:{name:"Indonesia"}}},{id:"11981",title:"Prof.",name:"Hiroshi",middleName:null,surname:"Ishiguro",slug:"hiroshi-ishiguro",fullName:"Hiroshi Ishiguro",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRglaQAC/Profile_Picture_1626411846553",biography:"Hiroshi Ishiguro is an award-winning roboticist and innovator. As the Director of the Intelligent Robotics Laboratory, which is part of the Department of Systems Innovation in the Graduate School of Engineering Science at Osaka University, Japan, Ishiguro concentrates on making robots that are similar as possible to humans to understand the human species. A notable project of his laboratory is the Actroid, a humanoid robot with a lifelike appearance and observable behavior such as facial movements. (Sources: http://www.geminoid.jp/en/index.html, https://en.wikipedia.org/wiki/Hiroshi_Ishiguro)",institutionString:null,institution:{name:"Osaka University",country:{name:"Japan"}}},{id:"45747",title:"Dr.",name:"Hsin-I",middleName:null,surname:"Chang",slug:"hsin-i-chang",fullName:"Hsin-I Chang",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Chiayi University",country:{name:"Taiwan"}}},{id:"61581",title:"Dr.",name:"Joy Rizki Pangestu",middleName:null,surname:"Djuansjah",slug:"joy-rizki-pangestu-djuansjah",fullName:"Joy Rizki Pangestu Djuansjah",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/61581/images/237_n.jpg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"94249",title:"Prof.",name:"Junji",middleName:null,surname:"Kido",slug:"junji-kido",fullName:"Junji Kido",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Yamagata University",country:{name:"Japan"}}},{id:"12009",title:"Dr.",name:"Ki Young",middleName:null,surname:"Kim",slug:"ki-young-kim",fullName:"Ki Young Kim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12009/images/system/12009.jpg",biography:"Http://m80.knu.ac.kr/~doors",institutionString:null,institution:{name:"National Cheng Kung University",country:{name:"Taiwan"}}},{id:"132595",title:"Prof.",name:"Long",middleName:null,surname:"Wang",slug:"long-wang",fullName:"Long Wang",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Peking University",country:{name:"China"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6675},{group:"region",caption:"Middle and South America",value:2,count:5955},{group:"region",caption:"Africa",value:3,count:2458},{group:"region",caption:"Asia",value:4,count:12717},{group:"region",caption:"Australia and Oceania",value:5,count:1017},{group:"region",caption:"Europe",value:6,count:17720}],offset:12,limit:12,total:12718},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{topicId:"17"},books:[{type:"book",id:"11464",title:"Carbon Nanotubes - Recent Advances, New Perspectives and Potential Applications",subtitle:null,isOpenForSubmission:!0,hash:"ce526ec78ed00c4f5f08ffb4548ff388",slug:null,bookSignature:"Prof. Mohammed Muzibur Rahman, Dr. Abdullah Mohammed Ahmed Asiri and Prof. Mohammad Asaduzzaman Chowdhury",coverURL:"https://cdn.intechopen.com/books/images_new/11464.jpg",editedByType:null,editors:[{id:"24438",title:"Prof.",name:"Mohammed Muzibur",surname:"Rahman",slug:"mohammed-muzibur-rahman",fullName:"Mohammed Muzibur Rahman"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11754",title:"Nanozymes - Simulation, Design, and Applications",subtitle:null,isOpenForSubmission:!0,hash:"7d040dd70e3021d1c7da668be1263616",slug:null,bookSignature:"D.Sc. Rafael Vargas-Bernal",coverURL:"https://cdn.intechopen.com/books/images_new/11754.jpg",editedByType:null,editors:[{id:"182114",title:"D.Sc.",name:"Rafael",surname:"Vargas-Bernal",slug:"rafael-vargas-bernal",fullName:"Rafael Vargas-Bernal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11755",title:"Nanoclay - Recent Advances, New Perspectives and Applications",subtitle:null,isOpenForSubmission:!0,hash:"b716126dd284217d47a657db8ae22ef4",slug:null,bookSignature:"Dr. Walid Oueslati",coverURL:"https://cdn.intechopen.com/books/images_new/11755.jpg",editedByType:null,editors:[{id:"176192",title:"Dr.",name:"Walid",surname:"Oueslati",slug:"walid-oueslati",fullName:"Walid Oueslati"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11756",title:"Quantum Dots - Recent Advances, New Perspectives and Contemporary Applications",subtitle:null,isOpenForSubmission:!0,hash:"0dd5611c62c91569bd2819e68852002a",slug:null,bookSignature:"Prof. Jagannathan Thirumalai",coverURL:"https://cdn.intechopen.com/books/images_new/11756.jpg",editedByType:null,editors:[{id:"99242",title:"Prof.",name:"Jagannathan",surname:"Thirumalai",slug:"jagannathan-thirumalai",fullName:"Jagannathan Thirumalai"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11757",title:"Nanorods - Synthesis, Properties, Toxicity and Applications",subtitle:null,isOpenForSubmission:!0,hash:"fb27f444442e8f039b560beae93e6873",slug:null,bookSignature:"Prof. Tejendra Kumar Gupta",coverURL:"https://cdn.intechopen.com/books/images_new/11757.jpg",editedByType:null,editors:[{id:"345089",title:"Prof.",name:"Tejendra Kumar",surname:"Gupta",slug:"tejendra-kumar-gupta",fullName:"Tejendra Kumar Gupta"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12259",title:"Nanopores",subtitle:null,isOpenForSubmission:!0,hash:"f170098e663d39a3431be01f1afeece8",slug:null,bookSignature:"Dr. Suresh Sagadevan",coverURL:"https://cdn.intechopen.com/books/images_new/12259.jpg",editedByType:null,editors:[{id:"473599",title:"Dr.",name:"Suresh",surname:"Sagadevan",slug:"suresh-sagadevan",fullName:"Suresh Sagadevan"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:38},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:13},{group:"topic",caption:"Business, Management and Economics",value:7,count:7},{group:"topic",caption:"Chemistry",value:8,count:23},{group:"topic",caption:"Computer and Information Science",value:9,count:24},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:65},{group:"topic",caption:"Environmental Sciences",value:12,count:10},{group:"topic",caption:"Immunology and Microbiology",value:13,count:16},{group:"topic",caption:"Materials Science",value:14,count:25},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:116},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:6},{group:"topic",caption:"Neuroscience",value:18,count:4},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:9},{group:"topic",caption:"Physics",value:20,count:9},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:12,limit:12,total:6},popularBooks:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4431},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1677,editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1337,editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1309,editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:847,editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",publishedDate:"June 15th 2022",numberOfDownloads:2273,editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:591,editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:515,editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:413,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",publishedDate:"June 8th 2022",numberOfDownloads:2194,editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:341,editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"11043",title:"Endometriosis",subtitle:"Recent Advances, New Perspectives and Treatments",isOpenForSubmission:!1,hash:"7baf1c70b11d41400bb9302ae9411ca4",slug:"endometriosis-recent-advances-new-perspectives-and-treatments",bookSignature:"Giovana Ap. Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/11043.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"185930",title:"Associate Prof.",name:"Giovana",middleName:null,surname:"Gonçalves",slug:"giovana-goncalves",fullName:"Giovana Gonçalves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10536",title:"Campylobacter",subtitle:null,isOpenForSubmission:!1,hash:"c4b132b741dd0a2ed539b824ab63965f",slug:"campylobacter",bookSignature:"Guillermo Tellez-Isaias and Saeed El-Ashram",coverURL:"https://cdn.intechopen.com/books/images_new/10536.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"73465",title:"Dr.",name:"Guillermo",middleName:null,surname:"Téllez",slug:"guillermo-tellez",fullName:"Guillermo Téllez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",isOpenForSubmission:!1,hash:"f197f6062c1574a9a90e50a369271bcf",slug:"starch-evolution-and-recent-advances",bookSignature:"Martins Ochubiojo Emeje",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11083",title:"Hazardous Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"d553bd4f6f1c4b115ca69bd19faac7dc",slug:"hazardous-waste-management",bookSignature:"Rajesh Banu Jeyakumar, Kavitha Sankarapandian and Yukesh Kannah Ravi",coverURL:"https://cdn.intechopen.com/books/images_new/11083.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"218539",title:"Dr.",name:"Rajesh Banu",middleName:null,surname:"Jeyakumar",slug:"rajesh-banu-jeyakumar",fullName:"Rajesh Banu Jeyakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10848",title:"Tribology of Machine Elements",subtitle:"Fundamentals and Applications",isOpenForSubmission:!1,hash:"3c4ca4c4692ca8d4fa749b4ae81ec1fa",slug:"tribology-of-machine-elements-fundamentals-and-applications",bookSignature:"Giuseppe Pintaude, Tiago Cousseau and Anna Rudawska",coverURL:"https://cdn.intechopen.com/books/images_new/10848.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"18347",title:"Prof.",name:"Giuseppe",middleName:null,surname:"Pintaude",slug:"giuseppe-pintaude",fullName:"Giuseppe Pintaude"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10856",title:"Crude Oil",subtitle:"New Technologies and Recent Approaches",isOpenForSubmission:!1,hash:"8d0a7ca35b3de95b295dc4eab39a087e",slug:"crude-oil-new-technologies-and-recent-approaches",bookSignature:"Manar Elsayed Abdel-Raouf and Mohamed Hasan El-Keshawy",coverURL:"https://cdn.intechopen.com/books/images_new/10856.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"102626",title:"Prof.",name:"Manar",middleName:null,surname:"Elsayed Abdel-Raouf",slug:"manar-elsayed-abdel-raouf",fullName:"Manar Elsayed Abdel-Raouf"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9625",title:"Spinocerebellar Ataxia",subtitle:"Concepts, Particularities and Generalities",isOpenForSubmission:!1,hash:"365a7025fd46eb45de2549bdd9d50b98",slug:"spinocerebellar-ataxia-concepts-particularities-and-generalities",bookSignature:"Patricia Bozzetto Ambrosi",coverURL:"https://cdn.intechopen.com/books/images_new/9625.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"221787",title:"Dr.",name:"Patricia",middleName:null,surname:"Bozzetto Ambrosi",slug:"patricia-bozzetto-ambrosi",fullName:"Patricia Bozzetto Ambrosi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10905",title:"Plant Defense Mechanisms",subtitle:null,isOpenForSubmission:!1,hash:"84ad5b27dde5f01dc76087d0fd6fa834",slug:"plant-defense-mechanisms",bookSignature:"Josphert Ngui Kimatu",coverURL:"https://cdn.intechopen.com/books/images_new/10905.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"224171",title:"Prof.",name:"Josphert N.",middleName:null,surname:"Kimatu",slug:"josphert-n.-kimatu",fullName:"Josphert N. Kimatu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10686",title:"Natural Gas",subtitle:"New Perspectives and Future Developments",isOpenForSubmission:!1,hash:"581763788a6a59e653a9d1d9b5a42d79",slug:"natural-gas-new-perspectives-and-future-developments",bookSignature:"Maryam Takht Ravanchi",coverURL:"https://cdn.intechopen.com/books/images_new/10686.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"2416",title:"Dr.",name:"Maryam",middleName:null,surname:"Takht Ravanchi",slug:"maryam-takht-ravanchi",fullName:"Maryam Takht Ravanchi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10988",title:"Railway Transport Planning and Manageme",subtitle:null,isOpenForSubmission:!1,hash:"5cb54cc53caedad9ec78372563c82e2c",slug:"railway-transport-planning-and-management",bookSignature:"Stefano de Luca, Roberta Di Pace and Chiara Fiori",coverURL:"https://cdn.intechopen.com/books/images_new/10988.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"271061",title:"Prof.",name:"Stefano",middleName:null,surname:"de Luca",slug:"stefano-de-luca",fullName:"Stefano de Luca"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"219",title:"Pharmacology",slug:"pharmacology-toxicology-and-pharmaceutical-science-pharmacology",parent:{id:"19",title:"Pharmacology, Toxicology and Pharmaceutical Science",slug:"pharmacology-toxicology-and-pharmaceutical-science"},numberOfBooks:52,numberOfSeries:0,numberOfAuthorsAndEditors:1306,numberOfWosCitations:1376,numberOfCrossrefCitations:863,numberOfDimensionsCitations:2108,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"219",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editedByType:"Edited by",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9829",title:"Biosimilars",subtitle:null,isOpenForSubmission:!1,hash:"c72171c1d1cf6df5aad989cb07cc8e4e",slug:"biosimilars",bookSignature:"Valderilio Feijó Azevedo and Robert Moots",coverURL:"https://cdn.intechopen.com/books/images_new/9829.jpg",editedByType:"Edited by",editors:[{id:"69875",title:"Dr.",name:"Valderilio",middleName:"Feijó",surname:"Feijó Azevedo",slug:"valderilio-feijo-azevedo",fullName:"Valderilio Feijó Azevedo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10881",title:"Drug Repurposing",subtitle:"Molecular Aspects and Therapeutic Applications",isOpenForSubmission:!1,hash:"eca3f2d5ca97b457d38a2442b36d3ac7",slug:"drug-repurposing-molecular-aspects-and-therapeutic-applications",bookSignature:"Shailendra K. Saxena",coverURL:"https://cdn.intechopen.com/books/images_new/10881.jpg",editedByType:"Edited by",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10234",title:"High-Throughput Screening for Drug Discovery",subtitle:null,isOpenForSubmission:!1,hash:"37e6f5b6dd0567efb63dca4b2c73495f",slug:"high-throughput-screening-for-drug-discovery",bookSignature:"Shailendra K. Saxena",coverURL:"https://cdn.intechopen.com/books/images_new/10234.jpg",editedByType:"Edited by",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11038",title:"Vaccine Development",subtitle:null,isOpenForSubmission:!1,hash:"2604d260662a3a3cc91971ea07beca61",slug:"vaccine-development",bookSignature:"Yulia Desheva",coverURL:"https://cdn.intechopen.com/books/images_new/11038.jpg",editedByType:"Edited by",editors:[{id:"233433",title:"Dr.",name:"Yulia",middleName:null,surname:"Desheva",slug:"yulia-desheva",fullName:"Yulia Desheva"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10357",title:"Drug Metabolism",subtitle:null,isOpenForSubmission:!1,hash:"3bd3ae5041cab45020555b49152b1ddc",slug:"drug-metabolism",bookSignature:"Katherine Dunnington",coverURL:"https://cdn.intechopen.com/books/images_new/10357.jpg",editedByType:"Edited by",editors:[{id:"232694",title:"Dr.",name:"Katherine",middleName:null,surname:"Dunnington",slug:"katherine-dunnington",fullName:"Katherine Dunnington"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10735",title:"Metformin",subtitle:"Pharmacology and Drug Interactions",isOpenForSubmission:!1,hash:"fee7e27a0fa000d000c459ff6e4b749e",slug:"metformin-pharmacology-and-drug-interactions",bookSignature:"Juber Akhtar, Usama Ahmad, Badruddeen and Mohammad Irfan Khan",coverURL:"https://cdn.intechopen.com/books/images_new/10735.jpg",editedByType:"Edited by",editors:[{id:"345595",title:"Prof.",name:"Juber",middleName:null,surname:"Akhtar",slug:"juber-akhtar",fullName:"Juber Akhtar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10716",title:"Corticosteroids",subtitle:"A Paradigmatic Drug Class",isOpenForSubmission:!1,hash:"d600ff66a3b0544bcbb713ea46287590",slug:"corticosteroids-a-paradigmatic-drug-class",bookSignature:"Celso Pereira",coverURL:"https://cdn.intechopen.com/books/images_new/10716.jpg",editedByType:"Edited by",editors:[{id:"66336",title:"Prof.",name:"Celso",middleName:null,surname:"Pereira",slug:"celso-pereira",fullName:"Celso Pereira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10578",title:"Pharmacogenetics",subtitle:null,isOpenForSubmission:!1,hash:"ca2bc2ff6e15a7b735d662d9664086b1",slug:"pharmacogenetics",bookSignature:"Islam A. Khalil",coverURL:"https://cdn.intechopen.com/books/images_new/10578.jpg",editedByType:"Edited by",editors:[{id:"226598",title:"Dr.",name:"Islam",middleName:null,surname:"A. Khalil",slug:"islam-a.-khalil",fullName:"Islam A. Khalil"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10236",title:"Plasmodium Species and Drug Resistance",subtitle:null,isOpenForSubmission:!1,hash:"964a389525d1147af3e527c056ac1a73",slug:"plasmodium-species-and-drug-resistance",bookSignature:"Rajeev K. Tyagi",coverURL:"https://cdn.intechopen.com/books/images_new/10236.jpg",editedByType:"Edited by",editors:[{id:"269120",title:"Dr.",name:"Rajeev",middleName:"K.",surname:"Tyagi",slug:"rajeev-tyagi",fullName:"Rajeev Tyagi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9833",title:"New Insights into the Future of Pharmacoepidemiology and Drug Safety",subtitle:null,isOpenForSubmission:!1,hash:"33c717cdacfd3327b4c5d516f96010e9",slug:"new-insights-into-the-future-of-pharmacoepidemiology-and-drug-safety",bookSignature:"Maria Teresa Herdeiro, Fátima Roque, Adolfo Figueiras and Tânia Magalhães Silva",coverURL:"https://cdn.intechopen.com/books/images_new/9833.jpg",editedByType:"Edited by",editors:[{id:"227508",title:"Prof.",name:"Maria Teresa",middleName:null,surname:"Herdeiro",slug:"maria-teresa-herdeiro",fullName:"Maria Teresa Herdeiro"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10232",title:"Theranostics",subtitle:"An Old Concept in New Clothing",isOpenForSubmission:!1,hash:"a283d1440c4b263c007d3f893f34c4f7",slug:"theranostics-an-old-concept-in-new-clothing",bookSignature:"Elisabeth Eppard",coverURL:"https://cdn.intechopen.com/books/images_new/10232.jpg",editedByType:"Edited by",editors:[{id:"245845",title:"Dr.",name:"Elisabeth",middleName:null,surname:"Eppard",slug:"elisabeth-eppard",fullName:"Elisabeth Eppard"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:52,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"40253",doi:"10.5772/50486",title:"Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development",slug:"lipid-nanoparticulate-drug-delivery-systems-a-revolution-in-dosage-form-design-and-development",totalDownloads:11245,totalCrossrefCites:21,totalDimensionsCites:103,abstract:null,book:{id:"2509",slug:"recent-advances-in-novel-drug-carrier-systems",title:"Recent Advances in Novel Drug Carrier Systems",fullTitle:"Recent Advances in Novel Drug Carrier Systems"},signatures:"Anthony A. Attama, Mumuni A. Momoh and Philip F. Builders",authors:[{id:"142947",title:"Prof.",name:"Anthony",middleName:null,surname:"Attama",slug:"anthony-attama",fullName:"Anthony Attama"}]},{id:"67939",doi:"10.5772/intechopen.85991",title:"Molecular Docking in Modern Drug Discovery: Principles and Recent Applications",slug:"molecular-docking-in-modern-drug-discovery-principles-and-recent-applications",totalDownloads:3853,totalCrossrefCites:25,totalDimensionsCites:59,abstract:"The process of hunt of a lead molecule is a long and a tedious process and one is often demoralized by the endless possibilities one has to search through. Fortunately, computational tools have come to the rescue and have undoubtedly played a pivotal role in rationalizing the path to drug discovery. Of all techniques, molecular docking has played a crucial role in computer aided drug design and has swiftly gained ranks to secure a valuable position in the modern scenario of structure-based drug design. In this chapter, the principle, sampling algorithms, scoring functions and diverse available software’s for molecular docking have been summarized. We demonstrate the interplay of docking, classical techniques of structure-based design and X-ray crystallography in the process of drug discovery. In addition, we dwell upon some of the limitations faced in docking studies. Finally, several success stories of molecular docking approaches in drug discovery have been highlighted, concluding with remarks on molecular docking for the future.",book:{id:"7867",slug:"drug-discovery-and-development-new-advances",title:"Drug Discovery and Development",fullTitle:"Drug Discovery and Development - New Advances"},signatures:"Aaftaab Sethi, Khusbhoo Joshi, K. Sasikala and Mallika Alvala",authors:[{id:"252956",title:"Dr.",name:"Mallika",middleName:null,surname:"Alvala",slug:"mallika-alvala",fullName:"Mallika Alvala"},{id:"287101",title:"Mr.",name:"Aaftaab",middleName:null,surname:"Sethi",slug:"aaftaab-sethi",fullName:"Aaftaab Sethi"},{id:"295049",title:"Ms.",name:"Khusbhoo",middleName:null,surname:"Joshi",slug:"khusbhoo-joshi",fullName:"Khusbhoo Joshi"},{id:"295050",title:"Ms.",name:"Sasikala",middleName:null,surname:"K",slug:"sasikala-k",fullName:"Sasikala K"}]},{id:"29240",doi:"10.5772/31087",title:"Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability",slug:"oral-absorption-intestinal-metabolism-and-human-oral-bioavailability-",totalDownloads:27075,totalCrossrefCites:27,totalDimensionsCites:57,abstract:null,book:{id:"672",slug:"topics-on-drug-metabolism",title:"Topics on Drug Metabolism",fullTitle:"Topics on Drug Metabolism"},signatures:"Ayman El-Kattan and Manthena Varma",authors:[{id:"85539",title:"Dr.",name:"Ayman",middleName:null,surname:"El-Kattan",slug:"ayman-el-kattan",fullName:"Ayman El-Kattan"},{id:"88221",title:"Dr.",name:"Manthena",middleName:null,surname:"Varma",slug:"manthena-varma",fullName:"Manthena Varma"}]},{id:"40262",doi:"10.5772/51384",title:"Nanotechnology in Drug Delivery",slug:"nanotechnology-in-drug-delivery",totalDownloads:15379,totalCrossrefCites:11,totalDimensionsCites:53,abstract:null,book:{id:"2509",slug:"recent-advances-in-novel-drug-carrier-systems",title:"Recent Advances in Novel Drug Carrier Systems",fullTitle:"Recent Advances in Novel Drug Carrier Systems"},signatures:"Martins Ochubiojo Emeje, Ifeoma Chinwude Obidike, Ekaete Ibanga Akpabio and Sabinus Ifianyi Ofoefule",authors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}]},{id:"40281",doi:"10.5772/52115",title:"Magnetic Nanoparticles: Synthesis, Surface Modifications and Application in Drug Delivery",slug:"magnetic-nanoparticles-synthesis-surface-modifications-and-application-in-drug-delivery",totalDownloads:12616,totalCrossrefCites:19,totalDimensionsCites:43,abstract:null,book:{id:"2509",slug:"recent-advances-in-novel-drug-carrier-systems",title:"Recent Advances in Novel Drug Carrier Systems",fullTitle:"Recent Advances in Novel Drug Carrier Systems"},signatures:"Seyda Bucak, Banu Yavuztürk and Ali Demir Sezer",authors:[{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"},{id:"129638",title:"Prof.",name:"Seyda",middleName:null,surname:"Bucak",slug:"seyda-bucak",fullName:"Seyda Bucak"}]}],mostDownloadedChaptersLast30Days:[{id:"49459",title:"Pharmacokinetics of Drugs Following IV Bolus, IV Infusion, and Oral Administration",slug:"pharmacokinetics-of-drugs-following-iv-bolus-iv-infusion-and-oral-administration",totalDownloads:15401,totalCrossrefCites:15,totalDimensionsCites:22,abstract:null,book:{id:"4491",slug:"basic-pharmacokinetic-concepts-and-some-clinical-applications",title:"Basic Pharmacokinetic Concepts and Some Clinical Applications",fullTitle:"Basic Pharmacokinetic Concepts and Some Clinical Applications"},signatures:"Tarek A. Ahmed",authors:[{id:"175649",title:"Dr.",name:"Tarek A",middleName:null,surname:"Ahmed",slug:"tarek-a-ahmed",fullName:"Tarek A Ahmed"}]},{id:"29240",title:"Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability",slug:"oral-absorption-intestinal-metabolism-and-human-oral-bioavailability-",totalDownloads:27075,totalCrossrefCites:27,totalDimensionsCites:57,abstract:null,book:{id:"672",slug:"topics-on-drug-metabolism",title:"Topics on Drug Metabolism",fullTitle:"Topics on Drug Metabolism"},signatures:"Ayman El-Kattan and Manthena Varma",authors:[{id:"85539",title:"Dr.",name:"Ayman",middleName:null,surname:"El-Kattan",slug:"ayman-el-kattan",fullName:"Ayman El-Kattan"},{id:"88221",title:"Dr.",name:"Manthena",middleName:null,surname:"Varma",slug:"manthena-varma",fullName:"Manthena Varma"}]},{id:"66742",title:"Introductory Chapter: Alkaloids - Their Importance in Nature and for Human Life",slug:"introductory-chapter-alkaloids-their-importance-in-nature-and-for-human-life",totalDownloads:4035,totalCrossrefCites:14,totalDimensionsCites:29,abstract:null,book:{id:"6828",slug:"alkaloids-their-importance-in-nature-and-human-life",title:"Alkaloids",fullTitle:"Alkaloids - Their Importance in Nature and Human Life"},signatures:"Joanna Kurek",authors:[{id:"214632",title:"Dr.",name:"Joanna",middleName:null,surname:"Kurek",slug:"joanna-kurek",fullName:"Joanna Kurek"}]},{id:"65128",title:"Natural Products in Drug Discovery",slug:"natural-products-in-drug-discovery",totalDownloads:6591,totalCrossrefCites:17,totalDimensionsCites:42,abstract:"Drug discovery using natural products is a challenging task for designing new leads. It describe the bioactive compounds derived from natural resources, its phytochemical analysis, characterization and pharmacological investigation. It focuses on the success of these resources in the process of finding and discovering new and effective drug compounds that can be useful for human resources. From many years, natural products have been acting as a source of therapeutic agents and have shown beneficial uses. Only natural product drug discovery plays an important role to develop the scientific evidence of these natural resources. Research in drug discovery needs to develop robust and viable lead molecules, which step forward from a screening hit to a drug candidate through structural elucidation and structure identification through GC–MS, NMR, IR, HPLC, and HPTLC. The development of new technologies has revolutionized the screening of natural products in discovering new drugs. Utilizing these technologies gives us an opportunity to perform research in screening new molecules using a software and database to establish natural products as a major source for drug discovery. It finally leads to lead structure discovery. Powerful new technologies are revolutionizing natural herbal drug discovery.",book:{id:"8290",slug:"pharmacognosy-medicinal-plants",title:"Pharmacognosy",fullTitle:"Pharmacognosy - Medicinal Plants"},signatures:"Akshada Amit Koparde, Rajendra Chandrashekar Doijad and Chandrakant Shripal Magdum",authors:[{id:"268668",title:"Dr.",name:"Akshada",middleName:"Amit",surname:"Koparde",slug:"akshada-koparde",fullName:"Akshada Koparde"}]},{id:"48805",title:"Biopharmaceutics and Pharmacokinetics",slug:"biopharmaceutics-and-pharmacokinetics",totalDownloads:26121,totalCrossrefCites:2,totalDimensionsCites:7,abstract:null,book:{id:"4491",slug:"basic-pharmacokinetic-concepts-and-some-clinical-applications",title:"Basic Pharmacokinetic Concepts and Some Clinical Applications",fullTitle:"Basic Pharmacokinetic Concepts and Some Clinical Applications"},signatures:"S. Lakshmana Prabu, T.N.K. Suriyaprakash, K. Ruckmani and R.\nThirumurugan",authors:[{id:"91590",title:"Dr.",name:"Sakthivel",middleName:null,surname:"Lakshmana Prabu",slug:"sakthivel-lakshmana-prabu",fullName:"Sakthivel Lakshmana Prabu"},{id:"128690",title:"Dr.",name:"Suriyaprakash",middleName:null,surname:"Tnk",slug:"suriyaprakash-tnk",fullName:"Suriyaprakash Tnk"}]}],onlineFirstChaptersFilter:{topicId:"219",limit:6,offset:0},onlineFirstChaptersCollection:[{id:"81238",title:"Artificial Intelligence in Healthcare: An Overview",slug:"artificial-intelligence-in-healthcare-an-overview",totalDownloads:31,totalDimensionsCites:0,doi:"10.5772/intechopen.102768",abstract:"The healthcare industry is advancing ahead swiftly. For many healthcare organizations, being able to forecast which treatment techniques are likely to be successful with patients based on their makeup and treatment framework is a big step forward. Artificial intelligence has the potential to help healthcare providers in a variety of ways, including patient care and administrative tasks. The technology aims to mimic human cognitive functions, as it offers numerous advantages over traditional analytics and other clinical decision-making tools. Data becomes more precise and accurate, allowing the healthcare industry to have more insights into the theranostic processes and patient outcomes. This chapter is an overview of the use of artificial intelligence in radiology, cardiology, ophthalmology, and drug discovery process.",book:{id:"10882",title:"Smart Drug Delivery",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg"},signatures:"Syed Shahwar Anwar, Usama Ahmad, Mohd Muazzam Khan, Md. Faheem Haider and Juber Akhtar"},{id:"79411",title:"Phospholipid Based Nano Drug Delivery Systems of Phytoconstituents",slug:"phospholipid-based-nano-drug-delivery-systems-of-phytoconstituents",totalDownloads:121,totalDimensionsCites:0,doi:"10.5772/intechopen.101040",abstract:"The development of phytochemistry and phyto-pharmacology has enabled elucidation of composition and biological activities of several medicinal plant constituents. However phytoconstituents are poorly absorbed due to their low aqueous solubility, large molecular size and poor membrane permeability when taken orally. Nanotechnology based drug delivery systems can be used to improve the dissolution rate, permeability and stability of these phytoconstituents. The current chapter aims to present the extraction of phytoconstituents, their identifications, and development/utilization of phospholipid based nano drug delivery systems (PBNDDS). The content of the chapter also provides characteristic features, in-vitro, in-vivo evaluations and stability performance of PBNDDS. The results from the UHPLC and GC-MS showed different phytoconstituents in the extracted samples with quantitative value. Dynamic light scattering (DLS) data showed PBNDDS of different phytoconstituents in the range of 50–250 nm with PDI value of 0.02–0.5, which was also confirmed by the electron microscopic data. Phytoconstituents loading or entrapment for PBNDDS was in the range of 60–95%. PBNDDS exhibited better in-vitro and in-vivo performance with improved Physico-chemical stability.",book:{id:"10882",title:"Smart Drug Delivery",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg"},signatures:"Mohammad Hossain Shariare and Mohsin Kazi"},{id:"79292",title:"Aliphatic Polyester Nanoparticles for Drug Delivery Systems",slug:"aliphatic-polyester-nanoparticles-for-drug-delivery-systems",totalDownloads:109,totalDimensionsCites:0,doi:"10.5772/intechopen.100977",abstract:"Drug delivery systems using aliphatic polyester nanoparticles are usually prepared via an emulsion process. These nanoparticles can control drug release and improve pharmacokinetics. Aliphatic polyesters are linear polymers containing ester linkages, showing sensitivity to hydrolytic degradation. The byproducts then promote autocatalytic degradation. These byproducts could enter the Krebs cycle and be eliminated from the body, resulting in the high biocompatibility of these nanoparticles. The properties of these polyesters are linked to the drug release rate due to biodegradation, i.e., polymer crystallinity, glass transition temperature, polymer hydrophobicity, and molecular weight (MW), all of which relatively influence hydrolysis. Mathematical equations have been used to study the factors and mechanisms that affect drug dissolution compared to experimental release data. The equations used as models for predicting the kinetics of drug release include the zero-order, first-order, Higuchi, Hixson-Crowell, and Korsmeyer-Peppas equations. Aliphatic polyester-based controlled drug delivery has surrounded much of the current activity in the estimation parameters of nanoparticles and stimulated additional research. Polymeric nanoparticles have potential in a wide range of applications, such as in biotechnology, vaccine systems, and the pharmaceutical industry. The main goal of this chapter is to discuss aliphatic polyester nanoparticles as drug carrier systems.",book:{id:"10882",title:"Smart Drug Delivery",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg"},signatures:"Narumol Kreua-ongarjnukool, Nopparuj Soomherun, Saowapa Thumsing Niyomthai and Sorayouth Chumnanvej"},{id:"78844",title:"Targeted Nano-Drug Delivery System to Colon Cancer",slug:"targeted-nano-drug-delivery-system-to-colon-cancer",totalDownloads:123,totalDimensionsCites:0,doi:"10.5772/intechopen.100059",abstract:"Cancer has been considered as the most cause of death in world. Employing of nanocarriers as drug delivery systems provide a platform for delivering drugs with increasing the anti-cancer efficacy, enhancing bioavailability of drugs, reducing side effects, enhancing the circulation half-life of drugs, improving the distribution of drugs and overcoming drug resistance. A number of nanocarriers have been studied as drug delivery systems for improving the treatment of cancer including liposomes, micelle, polymeric nanoparticles, carbon nanotubes, dendrimers, solid lipid nanoparticle (SLN) and nanostructure lipid carrier (NLC). In order to enhance recognition and internalization of nanocarriers by the target tissues, their surfaces can be modified with targeting ligands such as integrins, transferrin, folic acid, polysaccharides and antibodies. In this chapter, we are going to introduce the targeted nanocarriers for improving the cytotoxic action of drugs with further attempt of decreasing dose to achieve higher anticancer activity. Targeted nanocarriers would provide a promising therapeutic approach for cancer.",book:{id:"10882",title:"Smart Drug Delivery",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg"},signatures:"Eskandar Moghimipour and Somayeh Handali"},{id:"78619",title:"Strategies to Develop Cyclodextrin-Based Nanosponges for Smart Drug Delivery",slug:"strategies-to-develop-cyclodextrin-based-nanosponges-for-smart-drug-delivery",totalDownloads:128,totalDimensionsCites:1,doi:"10.5772/intechopen.100182",abstract:"In recent years, the development of various cyclodextrin (CD)-based nanosponges (NSs) has gained great importance in the controlled and-or targeted release of drugs due to their versatility and simple preparation. In this chapter, an introduction of different administration routes is explained. Further, different ways to obtain CD-NSs and their classification are shown with a brief explanation of the characterization of the inclusion complexes. Finally, illustrative examples in diverse processes or diseases will be reviewed and explained to demonstrate the potential of CD-NSs. Therefore, this division will serve to compile information on CD-NSs in recent years and to illustrate to readers how to generate and apply different derivatives of interest.",book:{id:"10882",title:"Smart Drug Delivery",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg"},signatures:"Gjylije Hoti, Silvia Lucia Appleton, Alberto Rubin Pedrazzo, Claudio Cecone, Adrián Matencio, Francesco Trotta and Fabrizio Caldera"},{id:"78313",title:"Smart Drug-Delivery Systems in the Treatment of Rheumatoid Arthritis: Current, Future Perspectives",slug:"smart-drug-delivery-systems-in-the-treatment-of-rheumatoid-arthritis-current-future-perspectives",totalDownloads:204,totalDimensionsCites:0,doi:"10.5772/intechopen.99641",abstract:"Rheumatoid arthritis (RA) is a progressive autoimmune inflammatory disorder characterized by cellular infiltration in synovium causing joint destruction and bone erosion. The heterogeneous nature of the disease manifests in different clinical forms, hence treatment of RA still remains obscure. Treatments are limited owing to systemic toxicity by dose-escalation and lack of selectivity. To overcome these limitations, Smart drug delivery systems (SDDS) are under investigation to exploit the arthritic microenvironment either by passive targeting or active targeting to the inflamed joints via folate receptor, CD44, angiogenesis, integrins. This review comprehensively deliberates upon understanding the pathophysiology of RA and role of SDDSs, highlighting the emerging trends for RA nanotherapeutics.",book:{id:"10882",title:"Smart Drug Delivery",coverURL:"https://cdn.intechopen.com/books/images_new/10882.jpg"},signatures:"Largee Biswas, Vikas Shukla, Vijay Kumar and Anita Kamra Verma"}],onlineFirstChaptersTotal:7},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:89,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:318,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:15,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"June 29th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:32,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"14",title:"Cell and Molecular Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",isOpenForSubmission:!0,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"15",title:"Chemical Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",isOpenForSubmission:!0,editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",slug:"sukru-beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",biography:"Dr. Şükrü Beydemir obtained a BSc in Chemistry in 1995 from Yüzüncü Yıl University, MSc in Biochemistry in 1998, and PhD in Biochemistry in 2002 from Atatürk University, Turkey. He performed post-doctoral studies at Max-Planck Institute, Germany, and University of Florence, Italy in addition to making several scientific visits abroad. He currently works as a Full Professor of Biochemistry in the Faculty of Pharmacy, Anadolu University, Turkey. Dr. Beydemir has published over a hundred scientific papers spanning protein biochemistry, enzymology and medicinal chemistry, reviews, book chapters and presented several conferences to scientists worldwide. He has received numerous publication awards from various international scientific councils. He serves in the Editorial Board of several international journals. Dr. Beydemir is also Rector of Bilecik Şeyh Edebali University, Turkey.",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",slug:"deniz-ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",biography:"Dr. Deniz Ekinci obtained a BSc in Chemistry in 2004, MSc in Biochemistry in 2006, and PhD in Biochemistry in 2009 from Atatürk University, Turkey. He studied at Stetson University, USA, in 2007-2008 and at the Max Planck Institute of Molecular Cell Biology and Genetics, Germany, in 2009-2010. Dr. Ekinci currently works as a Full Professor of Biochemistry in the Faculty of Agriculture and is the Head of the Enzyme and Microbial Biotechnology Division, Ondokuz Mayıs University, Turkey. He is a member of the Turkish Biochemical Society, American Chemical Society, and German Genetics society. Dr. Ekinci published around ninety scientific papers, reviews and book chapters, and presented several conferences to scientists. He has received numerous publication awards from several scientific councils. Dr. Ekinci serves as the Editor in Chief of four international books and is involved in the Editorial Board of several international journals.",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null},{id:"17",title:"Metabolism",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",isOpenForSubmission:!0,editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",slug:"yannis-karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",biography:"Yannis Karamanos, born in Greece in 1953, completed his pre-graduate studies at the Université Pierre et Marie Curie, Paris, then his Masters and Doctoral degree at the Université de Lille (1983). He was associate professor at the University of Limoges (1987) before becoming full professor of biochemistry at the Université d’Artois (1996). He worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-β-D-glucosaminidase and peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase). From 2002 he contributes to the understanding of the Blood-brain barrier functioning using proteomics approaches. He has published more than 70 papers. His teaching areas are energy metabolism and regulation, integration and organ specialization and metabolic adaptation.",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null},{id:"18",title:"Proteomics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",isOpenForSubmission:!0,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:36,paginationItems:[{id:"82195",title:"Endoplasmic Reticulum: A Hub in Lipid Homeostasis",doi:"10.5772/intechopen.105450",signatures:"Raúl Ventura and María Isabel Hernández-Alvarez",slug:"endoplasmic-reticulum-a-hub-in-lipid-homeostasis",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"82409",title:"Purinergic Signaling in Covid-19 Disease",doi:"10.5772/intechopen.105008",signatures:"Hailian Shen",slug:"purinergic-signaling-in-covid-19-disease",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82374",title:"The Potential of the Purinergic System as a Therapeutic Target of Natural Compounds in Cutaneous Melanoma",doi:"10.5772/intechopen.105457",signatures:"Gilnei Bruno da Silva, Daiane Manica, Marcelo Moreno and Margarete Dulce Bagatini",slug:"the-potential-of-the-purinergic-system-as-a-therapeutic-target-of-natural-compounds-in-cutaneous-mel",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"82103",title:"The Role of Endoplasmic Reticulum Stress and Its Regulation in the Progression of Neurological and Infectious Diseases",doi:"10.5772/intechopen.105543",signatures:"Mary Dover, Michael Kishek, Miranda Eddins, Naneeta Desar, Ketema Paul and Milan Fiala",slug:"the-role-of-endoplasmic-reticulum-stress-and-its-regulation-in-the-progression-of-neurological-and-i",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Updates on Endoplasmic Reticulum",coverURL:"https://cdn.intechopen.com/books/images_new/11674.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}}]},overviewPagePublishedBooks:{paginationCount:32,paginationItems:[{type:"book",id:"7006",title:"Biochemistry and Health Benefits of Fatty Acids",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7006.jpg",slug:"biochemistry-and-health-benefits-of-fatty-acids",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Viduranga Waisundara",hash:"c93a00abd68b5eba67e5e719f67fd20b",volumeInSeries:1,fullTitle:"Biochemistry and Health Benefits of Fatty Acids",editors:[{id:"194281",title:"Dr.",name:"Viduranga Y.",middleName:null,surname:"Waisundara",slug:"viduranga-y.-waisundara",fullName:"Viduranga Y. Waisundara",profilePictureURL:"https://mts.intechopen.com/storage/users/194281/images/system/194281.jpg",biography:"Dr. Viduranga Waisundara obtained her Ph.D. in Food Science\nand Technology from the Department of Chemistry, National\nUniversity of Singapore, in 2010. She was a lecturer at Temasek Polytechnic, Singapore from July 2009 to March 2013.\nShe relocated to her motherland of Sri Lanka and spearheaded the Functional Food Product Development Project at the\nNational Institute of Fundamental Studies from April 2013 to\nOctober 2016. She was a senior lecturer on a temporary basis at the Department of\nFood Technology, Faculty of Technology, Rajarata University of Sri Lanka. She is\ncurrently Deputy Principal of the Australian College of Business and Technology –\nKandy Campus, Sri Lanka. She is also the Global Harmonization Initiative (GHI)",institutionString:"Australian College of Business & Technology",institution:null}]},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}]},{type:"book",id:"7978",title:"Vitamin A",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7978.jpg",slug:"vitamin-a",publishedDate:"May 15th 2019",editedByType:"Edited by",bookSignature:"Leila Queiroz Zepka, Veridiana Vera de Rosso and Eduardo Jacob-Lopes",hash:"dad04a658ab9e3d851d23705980a688b",volumeInSeries:3,fullTitle:"Vitamin A",editors:[{id:"261969",title:"Dr.",name:"Leila",middleName:null,surname:"Queiroz Zepka",slug:"leila-queiroz-zepka",fullName:"Leila Queiroz Zepka",profilePictureURL:"https://mts.intechopen.com/storage/users/261969/images/system/261969.png",biography:"Prof. Dr. Leila Queiroz Zepka is currently an associate professor in the Department of Food Technology and Science, Federal University of Santa Maria, Brazil. She has more than fifteen years of teaching and research experience. She has published more than 550 scientific publications/communications, including 15 books, 50 book chapters, 100 original research papers, 380 research communications in national and international conferences, and 12 patents. She is a member of the editorial board of five journals and acts as a reviewer for several national and international journals. Her research interests include microalgal biotechnology with an emphasis on microalgae-based products.",institutionString:"Universidade Federal de Santa Maria",institution:{name:"Universidade Federal de Santa Maria",institutionURL:null,country:{name:"Brazil"}}}]},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",biography:"Dr. Hirobumi Suzuki received his Ph.D. in 1997 from Tokyo Metropolitan University, Japan, where he studied firefly phylogeny and the evolution of mating systems. He is especially interested in the genetic differentiation pattern and speciation process that correlate to the flashing pattern and mating behavior of some fireflies in Japan. He then worked for Olympus Corporation, a Japanese manufacturer of optics and imaging products, where he was involved in the development of luminescence technology and produced a bioluminescence microscope that is currently being used for gene expression analysis in chronobiology, neurobiology, and developmental biology. Dr. Suzuki currently serves as a visiting researcher at Kogakuin University, Japan, and also a vice president of the Japan Firefly Society.",institutionString:"Kogakuin University",institution:null}]}]},openForSubmissionBooks:{paginationCount:1,paginationItems:[{id:"11478",title:"Recent Advances in the Study of Dyslexia",coverURL:"https://cdn.intechopen.com/books/images_new/11478.jpg",hash:"26764a18c6b776698823e0e1c3022d2f",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"June 30th 2022",isOpenForSubmission:!0,editors:[{id:"294281",title:"Prof.",name:"Jonathan",surname:"Glazzard",slug:"jonathan-glazzard",fullName:"Jonathan Glazzard"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:54,paginationItems:[{id:"81595",title:"Prosthetic Concepts in Dental Implantology",doi:"10.5772/intechopen.104725",signatures:"Ivica Pelivan",slug:"prosthetic-concepts-in-dental-implantology",totalDownloads:25,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Current Concepts in Dental Implantology - From Science to Clinical Research",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"80963",title:"Pain Perception in Patients Treated with Ligating/Self-Ligating Brackets versus Patients Treated with Aligners",doi:"10.5772/intechopen.102796",signatures:"Farid Bourzgui, Rania Fastani, Salwa Khairat, Samir Diouny, Mohamed El Had, Zineb Serhier and Mohamed Bennani Othmani",slug:"pain-perception-in-patients-treated-with-ligating-self-ligating-brackets-versus-patients-treated-wit",totalDownloads:22,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Current Trends in Orthodontics",coverURL:"https://cdn.intechopen.com/books/images_new/10780.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"80964",title:"Upper Airway Expansion in Disabled Children",doi:"10.5772/intechopen.102830",signatures:"David Andrade, Joana Andrade, Maria-João Palha, Cristina Areias, Paula Macedo, Ana Norton, Miguel Palha, Lurdes Morais, Dóris Rocha Ruiz and Sônia Groisman",slug:"upper-airway-expansion-in-disabled-children",totalDownloads:35,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Oral Health Care - An Important Issue of the Modern Society",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"80839",title:"Herbs and Oral Health",doi:"10.5772/intechopen.103715",signatures:"Zuhair S. Natto",slug:"herbs-and-oral-health",totalDownloads:57,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Oral Health Care - An Important Issue of the Modern Society",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"80500",title:"Novel Dental Implants with Herbal Composites: A Review",doi:"10.5772/intechopen.101489",signatures:"Gopathy Sridevi and Seshadri Srividya",slug:"novel-dental-implants-with-herbal-composites-a-review",totalDownloads:49,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Current Concepts in Dental Implantology - From Science to Clinical Research",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"78320",title:"Implant-Retained Maxillary and Mandibular Overdentures - A Solution for Completely Edentulous Patients",doi:"10.5772/intechopen.99575",signatures:"Dubravka Knezović Zlatarić, Robert Ćelić and Hrvoje Pezo",slug:"implant-retained-maxillary-and-mandibular-overdentures-a-solution-for-completely-edentulous-patients",totalDownloads:66,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Current Concepts in Dental Implantology - From Science to Clinical Research",coverURL:"https://cdn.intechopen.com/books/images_new/10808.jpg",subseries:{id:"2",title:"Prosthodontics and Implant Dentistry"}}},{id:"80441",title:"Periodontitis and Heart Disease: Current Perspectives on the Associative Relationships and Preventive Impact",doi:"10.5772/intechopen.102669",signatures:"Alexandra Roman, Andrada Soancă, Bogdan Caloian, Alexandru Bucur, Gabriela Valentina Caracostea, Andreia Paraschiva Preda, Dora Maria Popescu, Iulia Cristina Micu, Petra Șurlin, Andreea Ciurea, Diana Oneț, Mircea Viorel Ciurea, Dragoș Alexandru Țermure and Marius Negucioiu",slug:"periodontitis-and-heart-disease-current-perspectives-on-the-associative-relationships-and-preventive",totalDownloads:54,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Oral Health Care - An Important Issue of the Modern Society",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"79498",title:"Oral Aspects and Dental Management of Special Needs Patient",doi:"10.5772/intechopen.101067",signatures:"Pinar Kiymet Karataban",slug:"oral-aspects-and-dental-management-of-special-needs-patient",totalDownloads:84,totalCrossrefCites:0,totalDimensionsCites:0,authors:[{name:"Pinar",surname:"Karataban"}],book:{title:"Oral Health Care - An Important Issue of the Modern Society",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"79699",title:"Metabolomics Distinction of Cigarette Smokers from Non-Smokers Using Non-Stationary Benchtop Nuclear Magnetic Resonance (NMR) Analysis of Human Saliva",doi:"10.5772/intechopen.101414",signatures:"Benita C. Percival, Angela Wann, Sophie Taylor, Mark Edgar, Miles Gibson and Martin Grootveld",slug:"metabolomics-distinction-of-cigarette-smokers-from-non-smokers-using-non-stationary-benchtop-nuclear",totalDownloads:54,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Oral Health Care - An Important Issue of the Modern Society",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",subseries:{id:"1",title:"Oral Health"}}},{id:"80295",title:"Preventive Methods and Treatments of White Spot Lesions in Orthodontics",doi:"10.5772/intechopen.102064",signatures:"Elif Nadide Akay",slug:"preventive-methods-and-treatments-of-white-spot-lesions-in-orthodontics",totalDownloads:82,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Oral Health Care - An Important Issue of the Modern Society",coverURL:"https://cdn.intechopen.com/books/images_new/10827.jpg",subseries:{id:"1",title:"Oral Health"}}}]},subseriesFiltersForOFChapters:[{caption:"Oral Health",value:1,count:20,group:"subseries"},{caption:"Prosthodontics and Implant Dentistry",value:2,count:34,group:"subseries"}],publishedBooks:{paginationCount:32,paginationItems:[{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",slug:"starch-evolution-and-recent-advances",publishedDate:"June 28th 2022",editedByType:"Edited by",bookSignature:"Martins Ochubiojo Emeje",hash:"f197f6062c1574a9a90e50a369271bcf",volumeInSeries:33,fullTitle:"Starch - Evolution and Recent Advances",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",slug:"essential-oils-advances-in-extractions-and-biological-applications",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",hash:"742e6cae3a35686f975edc8d7f9afa94",volumeInSeries:32,fullTitle:"Essential Oils - Advances in Extractions and Biological Applications",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira",profilePictureURL:"https://mts.intechopen.com/storage/users/195290/images/system/195290.png",institutionString:"Museu Paraense Emílio Goeldi",institution:{name:"Museu Paraense Emílio Goeldi",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10839",title:"Protein Detection",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10839.jpg",slug:"protein-detection",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Yusuf Tutar and Lütfi Tutar",hash:"2f1c0e4e0207fc45c936e7d22a5369c4",volumeInSeries:31,fullTitle:"Protein Detection",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar",profilePictureURL:"https://mts.intechopen.com/storage/users/158492/images/system/158492.jpeg",institutionString:"University of Health Sciences",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10797",title:"Cell Culture",subtitle:"Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",slug:"cell-culture-advanced-technology-and-applications-in-medical-and-life-sciences",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Xianquan Zhan",hash:"2c628f4757f9639a4450728d839a7842",volumeInSeries:30,fullTitle:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",editors:[{id:"223233",title:"Prof.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",profilePictureURL:"https://mts.intechopen.com/storage/users/223233/images/system/223233.png",institutionString:"Shandong First Medical University",institution:{name:"Affiliated Hospital of Shandong Academy of Medical Sciences",institutionURL:null,country:{name:"China"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",slug:"hydrolases",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Sajjad Haider, Adnan Haider and Angel Catalá",hash:"4e868cde273d65a7ff54b1817d640629",volumeInSeries:29,fullTitle:"Hydrolases",editors:[{id:"110708",title:"Dr.",name:"Sajjad",middleName:null,surname:"Haider",slug:"sajjad-haider",fullName:"Sajjad Haider",profilePictureURL:"https://mts.intechopen.com/storage/users/110708/images/system/110708.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",slug:"reactive-oxygen-species",publishedDate:"April 28th 2022",editedByType:"Edited by",bookSignature:"Rizwan Ahmad",hash:"176adcf090fdd1f93cb8ce3146e79ca1",volumeInSeries:28,fullTitle:"Reactive Oxygen Species",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/40482/images/system/40482.jpeg",institutionString:"Imam Abdulrahman Bin Faisal University",institution:{name:"Imam Abdulrahman Bin Faisal University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9008",title:"Vitamin K",subtitle:"Recent Topics on the Biology and Chemistry",coverURL:"https://cdn.intechopen.com/books/images_new/9008.jpg",slug:"vitamin-k-recent-topics-on-the-biology-and-chemistry",publishedDate:"March 23rd 2022",editedByType:"Edited by",bookSignature:"Hiroyuki Kagechika and Hitoshi Shirakawa",hash:"8b43add5389ba85743e0a9491e4b9943",volumeInSeries:27,fullTitle:"Vitamin K - Recent Topics on the Biology and Chemistry",editors:[{id:"180528",title:"Dr.",name:"Hiroyuki",middleName:null,surname:"Kagechika",slug:"hiroyuki-kagechika",fullName:"Hiroyuki Kagechika",profilePictureURL:"https://mts.intechopen.com/storage/users/180528/images/system/180528.jpg",institutionString:"Tokyo Medical and Dental University",institution:{name:"Tokyo Medical and Dental University",institutionURL:null,country:{name:"Japan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9659",title:"Fibroblasts",subtitle:"Advances in Inflammation, Autoimmunity and Cancer",coverURL:"https://cdn.intechopen.com/books/images_new/9659.jpg",slug:"fibroblasts-advances-in-inflammation-autoimmunity-and-cancer",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Mojca Frank Bertoncelj and Katja Lakota",hash:"926fa6446f6befbd363fc74971a56de2",volumeInSeries:25,fullTitle:"Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer",editors:[{id:"328755",title:"Ph.D.",name:"Mojca",middleName:null,surname:"Frank Bertoncelj",slug:"mojca-frank-bertoncelj",fullName:"Mojca Frank Bertoncelj",profilePictureURL:"https://mts.intechopen.com/storage/users/328755/images/system/328755.jpg",institutionString:"BioMed X Institute",institution:{name:"University Hospital of Zurich",institutionURL:null,country:{name:"Switzerland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8977",title:"Protein Kinases",subtitle:"Promising Targets for Anticancer Drug Research",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",slug:"protein-kinases-promising-targets-for-anticancer-drug-research",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Rajesh Kumar Singh",hash:"6d200cc031706a565b554fdb1c478901",volumeInSeries:24,fullTitle:"Protein Kinases - Promising Targets for Anticancer Drug Research",editors:[{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8018",title:"Extracellular Matrix",subtitle:"Developments and Therapeutics",coverURL:"https://cdn.intechopen.com/books/images_new/8018.jpg",slug:"extracellular-matrix-developments-and-therapeutics",publishedDate:"October 27th 2021",editedByType:"Edited by",bookSignature:"Rama Sashank Madhurapantula, Joseph Orgel P.R.O. and Zvi Loewy",hash:"c85e82851e80b40282ff9be99ddf2046",volumeInSeries:23,fullTitle:"Extracellular Matrix - Developments and Therapeutics",editors:[{id:"212416",title:"Dr.",name:"Rama Sashank",middleName:null,surname:"Madhurapantula",slug:"rama-sashank-madhurapantula",fullName:"Rama Sashank Madhurapantula",profilePictureURL:"https://mts.intechopen.com/storage/users/212416/images/system/212416.jpg",institutionString:"Illinois Institute of Technology",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9759",title:"Vitamin E in Health and Disease",subtitle:"Interactions, Diseases and Health Aspects",coverURL:"https://cdn.intechopen.com/books/images_new/9759.jpg",slug:"vitamin-e-in-health-and-disease-interactions-diseases-and-health-aspects",publishedDate:"October 6th 2021",editedByType:"Edited by",bookSignature:"Pınar Erkekoglu and Júlia Scherer Santos",hash:"6c3ddcc13626110de289b57f2516ac8f",volumeInSeries:22,fullTitle:"Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoğlu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoğlu",profilePictureURL:"https://mts.intechopen.com/storage/users/109978/images/system/109978.jpg",institutionString:"Hacettepe University",institution:{name:"Hacettepe University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Proteomics",value:18,count:4},{group:"subseries",caption:"Metabolism",value:17,count:6},{group:"subseries",caption:"Cell and Molecular Biology",value:14,count:9},{group:"subseries",caption:"Chemical Biology",value:15,count:13}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:8},{group:"publicationYear",caption:"2021",value:2021,count:7},{group:"publicationYear",caption:"2020",value:2020,count:12},{group:"publicationYear",caption:"2019",value:2019,count:3},{group:"publicationYear",caption:"2018",value:2018,count:2}],authors:{paginationCount:229,paginationItems:[{id:"318170",title:"Dr.",name:"Aneesa",middleName:null,surname:"Moolla",slug:"aneesa-moolla",fullName:"Aneesa Moolla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/318170/images/system/318170.png",biography:"Dr. Aneesa Moolla has extensive experience in the diverse fields of health care having previously worked in dental private practice, at the Red Cross Flying Doctors association, and in healthcare corporate settings. She is now a lecturer at the University of Witwatersrand, South Africa, and a principal researcher at the Health Economics and Epidemiology Research Office (HE2RO), South Africa. Dr. Moolla holds a Ph.D. in Psychology with her research being focused on mental health and resilience. In her professional work capacity, her research has further expanded into the fields of early childhood development, mental health, the HIV and TB care cascades, as well as COVID. She is also a UNESCO-trained International Bioethics Facilitator.",institutionString:"University of the Witwatersrand",institution:{name:"University of the Witwatersrand",country:{name:"South Africa"}}},{id:"419588",title:"Ph.D.",name:"Sergio",middleName:"Alexandre",surname:"Gehrke",slug:"sergio-gehrke",fullName:"Sergio Gehrke",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038WgMKQA0/Profile_Picture_2022-06-02T11:44:20.jpg",biography:"Dr. Sergio Alexandre Gehrke is a doctorate holder in two fields. The first is a Ph.D. in Cellular and Molecular Biology from the Pontificia Catholic University, Porto Alegre, Brazil, in 2010 and the other is an International Ph.D. in Bioengineering from the Universidad Miguel Hernandez, Elche/Alicante, Spain, obtained in 2020. In 2018, he completed a postdoctoral fellowship in Materials Engineering in the NUCLEMAT of the Pontificia Catholic University, Porto Alegre, Brazil. He is currently the Director of the Postgraduate Program in Implantology of the Bioface/UCAM/PgO (Montevideo, Uruguay), Director of the Cathedra of Biotechnology of the Catholic University of Murcia (Murcia, Spain), an Extraordinary Full Professor of the Catholic University of Murcia (Murcia, Spain) as well as the Director of the private center of research Biotecnos – Technology and Science (Montevideo, Uruguay). Applied biomaterials, cellular and molecular biology, and dental implants are among his research interests. He has published several original papers in renowned journals. In addition, he is also a Collaborating Professor in several Postgraduate programs at different universities all over the world.",institutionString:null,institution:{name:"Universidad Católica San Antonio de Murcia",country:{name:"Spain"}}},{id:"342152",title:"Dr.",name:"Santo",middleName:null,surname:"Grace Umesh",slug:"santo-grace-umesh",fullName:"Santo Grace Umesh",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/342152/images/16311_n.jpg",biography:null,institutionString:null,institution:{name:"SRM Dental College",country:{name:"India"}}},{id:"333647",title:"Dr.",name:"Shreya",middleName:null,surname:"Kishore",slug:"shreya-kishore",fullName:"Shreya Kishore",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/333647/images/14701_n.jpg",biography:"Dr. Shreya Kishore completed her Bachelor in Dental Surgery in Chettinad Dental College and Research Institute, Chennai, and her Master of Dental Surgery (Orthodontics) in Saveetha Dental College, Chennai. She is also Invisalign certified. She’s working as a Senior Lecturer in the Department of Orthodontics, SRM Dental College since November 2019. She is actively involved in teaching orthodontics to the undergraduates and the postgraduates. Her clinical research topics include new orthodontic brackets, fixed appliances and TADs. She’s published 4 articles in well renowned indexed journals and has a published patency of her own. Her private practice is currently limited to orthodontics and works as a consultant in various clinics.",institutionString:null,institution:{name:"SRM Dental College",country:{name:"India"}}},{id:"323731",title:"Prof.",name:"Deepak M.",middleName:"Macchindra",surname:"Vikhe",slug:"deepak-m.-vikhe",fullName:"Deepak M. Vikhe",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/323731/images/13613_n.jpg",biography:"Dr Deepak M.Vikhe .\n\n\t\n\tDr Deepak M.Vikhe , completed his Masters & PhD in Prosthodontics from Rural Dental College, Loni securing third rank in the Pravara Institute of Medical Sciences Deemed University. He was awarded Dr.G.C.DAS Memorial Award for Research on Implants at 39th IPS conference Dubai (U A E).He has two patents under his name. He has received Dr.Saraswati medal award for best research for implant study in 2017.He has received Fully funded scholarship to Spain ,university of Santiago de Compostela. He has completed fellowship in Implantlogy from Noble Biocare. \nHe has attended various conferences and CDE programmes and has national publications to his credit. His field of interest is in Implant supported prosthesis. Presently he is working as a associate professor in the Dept of Prosthodontics, Rural Dental College, Loni and maintains a successful private practice specialising in Implantology at Rahata.\n\nEmail: drdeepak_mvikhe@yahoo.com..................",institutionString:null,institution:{name:"Pravara Institute of Medical Sciences",country:{name:"India"}}},{id:"204110",title:"Dr.",name:"Ahmed A.",middleName:null,surname:"Madfa",slug:"ahmed-a.-madfa",fullName:"Ahmed A. Madfa",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/204110/images/system/204110.jpg",biography:"Dr. Madfa is currently Associate Professor of Endodontics at Thamar University and a visiting lecturer at Sana'a University and University of Sciences and Technology. He has more than 6 years of experience in teaching. His research interests include root canal morphology, functionally graded concept, dental biomaterials, epidemiology and dental education, biomimetic restoration, finite element analysis and endodontic regeneration. Dr. Madfa has numerous international publications, full articles, two patents, a book and a book chapter. Furthermore, he won 14 international scientific awards. Furthermore, he is involved in many academic activities ranging from editorial board member, reviewer for many international journals and postgraduate students' supervisor. Besides, I deliver many courses and training workshops at various scientific events. Dr. Madfa also regularly attends international conferences and holds administrative positions (Deputy Dean of the Faculty for Students’ & Academic Affairs and Deputy Head of Research Unit).",institutionString:"Thamar University",institution:null},{id:"210472",title:"Dr.",name:"Nermin",middleName:"Mohammed Ahmed",surname:"Yussif",slug:"nermin-yussif",fullName:"Nermin Yussif",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/210472/images/system/210472.jpg",biography:"Dr. Nermin Mohammed Ahmed Yussif is working at the Faculty of dentistry, University for October university for modern sciences and arts (MSA). Her areas of expertise include: periodontology, dental laserology, oral implantology, periodontal plastic surgeries, oral mesotherapy, nutrition, dental pharmacology. She is an editor and reviewer in numerous international journals.",institutionString:"MSA University",institution:null},{id:"204606",title:"Dr.",name:"Serdar",middleName:null,surname:"Gözler",slug:"serdar-gozler",fullName:"Serdar Gözler",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/204606/images/system/204606.jpeg",biography:"Dr. Serdar Gözler has completed his undergraduate studies at the Marmara University Faculty of Dentistry in 1978, followed by an assistantship in the Prosthesis Department of Dicle University Faculty of Dentistry. Starting his PhD work on non-resilient overdentures with Assoc. Prof. Hüsnü Yavuzyılmaz, he continued his studies with Prof. Dr. Gürbüz Öztürk of Istanbul University Faculty of Dentistry Department of Prosthodontics, this time on Gnatology. He attended training programs on occlusion, neurology, neurophysiology, EMG, radiology and biostatistics. In 1982, he presented his PhD thesis \\Gerber and Lauritzen Occlusion Analysis Techniques: Diagnosis Values,\\ at Istanbul University School of Dentistry, Department of Prosthodontics. As he was also working with Prof. Senih Çalıkkocaoğlu on The Physiology of Chewing at the same time, Gözler has written a chapter in Çalıkkocaoğlu\\'s book \\Complete Prostheses\\ entitled \\The Place of Neuromuscular Mechanism in Prosthetic Dentistry.\\ The book was published five times since by the Istanbul University Publications. Having presented in various conferences about occlusion analysis until 1998, Dr. Gözler has also decided to use the T-Scan II occlusion analysis method. Having been personally trained by Dr. Robert Kerstein on this method, Dr. Gözler has been lecturing on the T-Scan Occlusion Analysis Method in conferences both in Turkey and abroad. Dr. Gözler has various articles and presentations on Digital Occlusion Analysis methods. He is now Head of the TMD Clinic at Prosthodontic Department of Faculty of Dentistry , Istanbul Aydın University , Turkey.",institutionString:"Istanbul Aydin University",institution:{name:"Istanbul Aydın University",country:{name:"Turkey"}}},{id:"240870",title:"Ph.D.",name:"Alaa Eddin Omar",middleName:null,surname:"Al Ostwani",slug:"alaa-eddin-omar-al-ostwani",fullName:"Alaa Eddin Omar Al Ostwani",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/240870/images/system/240870.jpeg",biography:"Dr. Al Ostwani Alaa Eddin Omar received his Master in dentistry from Damascus University in 2010, and his Ph.D. in Pediatric Dentistry from Damascus University in 2014. Dr. Al Ostwani is an assistant professor and faculty member at IUST University since 2014. \nDuring his academic experience, he has received several awards including the scientific research award from the Union of Arab Universities, the Syrian gold medal and the international gold medal for invention and creativity. Dr. Al Ostwani is a Member of the International Association of Dental Traumatology and the Syrian Society for Research and Preventive Dentistry since 2017. He is also a Member of the Reviewer Board of International Journal of Dental Medicine (IJDM), and the Indian Journal of Conservative and Endodontics since 2016.",institutionString:"International University for Science and Technology.",institution:{name:"Islamic University of Science and Technology",country:{name:"India"}}},{id:"42847",title:"Dr.",name:"Belma",middleName:null,surname:"Işik Aslan",slug:"belma-isik-aslan",fullName:"Belma Işik Aslan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/42847/images/system/42847.jpg",biography:"Dr. Belma IşIk Aslan was born in 1976 in Ankara-TURKEY. After graduating from TED Ankara College in 1994, she attended to Gazi University, Faculty of Dentistry in Ankara. She completed her PhD in orthodontic education at Gazi University between 1999-2005. Dr. Işık Aslan stayed at the Providence Hospital Craniofacial Institude and Reconstructive Surgery in Michigan, USA for three months as an observer. She worked as a specialist doctor at Gazi University, Dentistry Faculty, Department of Orthodontics between 2005-2014. She was appointed as associate professor in January, 2014 and as professor in 2021. Dr. Işık Aslan still works as an instructor at the same faculty. She has published a total of 35 articles, 10 book chapters, 39 conference proceedings both internationally and nationally. Also she was the academic editor of the international book 'Current Advances in Orthodontics'. She is a member of the Turkish Orthodontic Society and Turkish Cleft Lip and Palate Society. She is married and has 2 children. Her knowledge of English is at an advanced level.",institutionString:"Gazi University Dentistry Faculty Department of Orthodontics",institution:null},{id:"178412",title:"Associate Prof.",name:"Guhan",middleName:null,surname:"Dergin",slug:"guhan-dergin",fullName:"Guhan Dergin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/178412/images/6954_n.jpg",biography:"Assoc. Prof. Dr. Gühan Dergin was born in 1973 in Izmit. He graduated from Marmara University Faculty of Dentistry in 1999. He completed his specialty of OMFS surgery in Marmara University Faculty of Dentistry and obtained his PhD degree in 2006. In 2005, he was invited as a visiting doctor in the Oral and Maxillofacial Surgery Department of the University of North Carolina, USA, where he went on a scholarship. Dr. Dergin still continues his academic career as an associate professor in Marmara University Faculty of Dentistry. He has many articles in international and national scientific journals and chapters in books.",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"178414",title:"Prof.",name:"Yusuf",middleName:null,surname:"Emes",slug:"yusuf-emes",fullName:"Yusuf Emes",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/178414/images/6953_n.jpg",biography:"Born in Istanbul in 1974, Dr. Emes graduated from Istanbul University Faculty of Dentistry in 1997 and completed his PhD degree in Istanbul University faculty of Dentistry Department of Oral and Maxillofacial Surgery in 2005. He has papers published in international and national scientific journals, including research articles on implantology, oroantral fistulas, odontogenic cysts, and temporomandibular disorders. Dr. Emes is currently working as a full-time academic staff in Istanbul University faculty of Dentistry Department of Oral and Maxillofacial Surgery.",institutionString:null,institution:{name:"Istanbul University",country:{name:"Turkey"}}},{id:"192229",title:"Ph.D.",name:"Ana Luiza",middleName:null,surname:"De Carvalho Felippini",slug:"ana-luiza-de-carvalho-felippini",fullName:"Ana Luiza De Carvalho Felippini",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/192229/images/system/192229.jpg",biography:null,institutionString:"University of São Paulo",institution:{name:"University of Sao Paulo",country:{name:"Brazil"}}},{id:"256851",title:"Prof.",name:"Ayşe",middleName:null,surname:"Gülşen",slug:"ayse-gulsen",fullName:"Ayşe Gülşen",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/256851/images/9696_n.jpg",biography:"Dr. Ayşe Gülşen graduated in 1990 from Faculty of Dentistry, University of Ankara and did a postgraduate program at University of Gazi. \nShe worked as an observer and research assistant in Craniofacial Surgery Departments in New York, Providence Hospital in Michigan and Chang Gung Memorial Hospital in Taiwan. \nShe works as Craniofacial Orthodontist in Department of Aesthetic, Plastic and Reconstructive Surgery, Faculty of Medicine, University of Gazi, Ankara Turkey since 2004.",institutionString:"Univeristy of Gazi",institution:null},{id:"255366",title:"Prof.",name:"Tosun",middleName:null,surname:"Tosun",slug:"tosun-tosun",fullName:"Tosun Tosun",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/255366/images/7347_n.jpg",biography:"Graduated at the Faculty of Dentistry, University of Istanbul, Turkey in 1989;\nVisitor Assistant at the University of Padua, Italy and Branemark Osseointegration Center of Treviso, Italy between 1993-94;\nPhD thesis on oral implantology in University of Istanbul and was awarded the academic title “Dr.med.dent.”, 1997;\nHe was awarded the academic title “Doç.Dr.” (Associated Professor) in 2003;\nProficiency in Botulinum Toxin Applications, Reading-UK in 2009;\nMastership, RWTH Certificate in Laser Therapy in Dentistry, AALZ-Aachen University, Germany 2009-11;\nMaster of Science (MSc) in Laser Dentistry, University of Genoa, Italy 2013-14.\n\nDr.Tosun worked as Research Assistant in the Department of Oral Implantology, Faculty of Dentistry, University of Istanbul between 1990-2002. \nHe worked part-time as Consultant surgeon in Harvard Medical International Hospitals and John Hopkins Medicine, Istanbul between years 2007-09.\u2028He was contract Professor in the Department of Surgical and Diagnostic Sciences (DI.S.C.), Medical School, University of Genova, Italy between years 2011-16. \nSince 2015 he is visiting Professor at Medical School, University of Plovdiv, Bulgaria. \nCurrently he is Associated Prof.Dr. at the Dental School, Oral Surgery Dept., Istanbul Aydin University and since 2003 he works in his own private clinic in Istanbul, Turkey.\u2028\nDr.Tosun is reviewer in journal ‘Laser in Medical Sciences’, reviewer in journal ‘Folia Medica\\', a Fellow of the International Team for Implantology, Clinical Lecturer of DGZI German Association of Oral Implantology, Expert Lecturer of Laser&Health Academy, Country Representative of World Federation for Laser Dentistry, member of European Federation of Periodontology, member of Academy of Laser Dentistry. Dr.Tosun presents papers in international and national congresses and has scientific publications in international and national journals. He speaks english, spanish, italian and french.",institutionString:null,institution:{name:"Istanbul Aydın University",country:{name:"Turkey"}}},{id:"171887",title:"Prof.",name:"Zühre",middleName:null,surname:"Akarslan",slug:"zuhre-akarslan",fullName:"Zühre Akarslan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/171887/images/system/171887.jpg",biography:"Zühre Akarslan was born in 1977 in Cyprus. She graduated from Gazi University Faculty of Dentistry, Ankara, Turkey in 2000. \r\nLater she received her Ph.D. degree from the Oral Diagnosis and Radiology Department; which was recently renamed as Oral and Dentomaxillofacial Radiology, from the same university. \r\nShe is working as a full-time Associate Professor and is a lecturer and an academic researcher. \r\nHer expertise areas are dental caries, cancer, dental fear and anxiety, gag reflex in dentistry, oral medicine, and dentomaxillofacial radiology.",institutionString:"Gazi University",institution:{name:"Gazi University",country:{name:"Turkey"}}},{id:"256417",title:"Associate Prof.",name:"Sanaz",middleName:null,surname:"Sadry",slug:"sanaz-sadry",fullName:"Sanaz Sadry",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/256417/images/8106_n.jpg",biography:null,institutionString:null,institution:null},{id:"272237",title:"Dr.",name:"Pinar",middleName:"Kiymet",surname:"Karataban",slug:"pinar-karataban",fullName:"Pinar Karataban",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/272237/images/8911_n.png",biography:"Assist.Prof.Dr.Pınar Kıymet Karataban, DDS PhD \n\nDr.Pınar Kıymet Karataban was born in Istanbul in 1975. After her graduation from Marmara University Faculty of Dentistry in 1998 she started her PhD in Paediatric Dentistry focused on children with special needs; mainly children with Cerebral Palsy. She finished her pHD thesis entitled \\'Investigation of occlusion via cast analysis and evaluation of dental caries prevalance, periodontal status and muscle dysfunctions in children with cerebral palsy” in 2008. She got her Assist. Proffessor degree in Istanbul Aydın University Paediatric Dentistry Department in 2015-2018. ın 2019 she started her new career in Bahcesehir University, Istanbul as Head of Department of Pediatric Dentistry. In 2020 she was accepted to BAU International University, Batumi as Professor of Pediatric Dentistry. She’s a lecturer in the same university meanwhile working part-time in private practice in Ege Dental Studio (https://www.egedisklinigi.com/) a multidisciplinary dental clinic in Istanbul. Her main interests are paleodontology, ancient and contemporary dentistry, oral microbiology, cerebral palsy and special care dentistry. She has national and international publications, scientific reports and is a member of IAPO (International Association for Paleodontology), IADH (International Association of Disability and Oral Health) and EAPD (European Association of Pediatric Dentistry).",institutionString:null,institution:null},{id:"202198",title:"Dr.",name:"Buket",middleName:null,surname:"Aybar",slug:"buket-aybar",fullName:"Buket Aybar",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202198/images/6955_n.jpg",biography:"Buket Aybar, DDS, PhD, was born in 1971. She graduated from Istanbul University, Faculty of Dentistry, in 1992 and completed her PhD degree on Oral and Maxillofacial Surgery in Istanbul University in 1997.\nDr. Aybar is currently a full-time professor in Istanbul University, Faculty of Dentistry Department of Oral and Maxillofacial Surgery. She has teaching responsibilities in graduate and postgraduate programs. Her clinical practice includes mainly dentoalveolar surgery.\nHer topics of interest are biomaterials science and cell culture studies. She has many articles in international and national scientific journals and chapters in books; she also has participated in several scientific projects supported by Istanbul University Research fund.",institutionString:null,institution:null},{id:"260116",title:"Dr.",name:"Mehmet",middleName:null,surname:"Yaltirik",slug:"mehmet-yaltirik",fullName:"Mehmet Yaltirik",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/260116/images/7413_n.jpg",biography:"Birth Date 25.09.1965\r\nBirth Place Adana- Turkey\r\nSex Male\r\nMarrial Status Bachelor\r\nDriving License Acquired\r\nMother Tongue Turkish\r\n\r\nAddress:\r\nWork:University of Istanbul,Faculty of Dentistry, Department of Oral Surgery and Oral Medicine 34093 Capa,Istanbul- TURKIYE",institutionString:null,institution:null},{id:"172009",title:"Dr.",name:"Fatma Deniz",middleName:null,surname:"Uzuner",slug:"fatma-deniz-uzuner",fullName:"Fatma Deniz Uzuner",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/172009/images/7122_n.jpg",biography:"Dr. Deniz Uzuner was born in 1969 in Kocaeli-TURKEY. After graduating from TED Ankara College in 1986, she attended the Hacettepe University, Faculty of Dentistry in Ankara. \nIn 1993 she attended the Gazi University, Faculty of Dentistry, Department of Orthodontics for her PhD education. After finishing the PhD education, she worked as orthodontist in Ankara Dental Hospital under the Turkish Government, Ministry of Health and in a special Orthodontic Clinic till 2011. Between 2011 and 2016, Dr. Deniz Uzuner worked as a specialist in the Department of Orthodontics, Faculty of Dentistry, Gazi University in Ankara/Turkey. In 2016, she was appointed associate professor. Dr. Deniz Uzuner has authored 23 Journal Papers, 3 Book Chapters and has had 39 oral/poster presentations. She is a member of the Turkish Orthodontic Society. Her knowledge of English is at an advanced level.",institutionString:null,institution:null},{id:"332914",title:"Dr.",name:"Muhammad Saad",middleName:null,surname:"Shaikh",slug:"muhammad-saad-shaikh",fullName:"Muhammad Saad Shaikh",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Jinnah Sindh Medical University",country:{name:"Pakistan"}}},{id:"315775",title:"Dr.",name:"Feng",middleName:null,surname:"Luo",slug:"feng-luo",fullName:"Feng Luo",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Sichuan University",country:{name:"China"}}},{id:"423519",title:"Dr.",name:"Sizakele",middleName:null,surname:"Ngwenya",slug:"sizakele-ngwenya",fullName:"Sizakele Ngwenya",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of the Witwatersrand",country:{name:"South Africa"}}},{id:"419270",title:"Dr.",name:"Ann",middleName:null,surname:"Chianchitlert",slug:"ann-chianchitlert",fullName:"Ann Chianchitlert",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Walailak University",country:{name:"Thailand"}}},{id:"419271",title:"Dr.",name:"Diane",middleName:null,surname:"Selvido",slug:"diane-selvido",fullName:"Diane Selvido",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Walailak University",country:{name:"Thailand"}}},{id:"419272",title:"Dr.",name:"Irin",middleName:null,surname:"Sirisoontorn",slug:"irin-sirisoontorn",fullName:"Irin Sirisoontorn",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Walailak University",country:{name:"Thailand"}}},{id:"355660",title:"Dr.",name:"Anitha",middleName:null,surname:"Mani",slug:"anitha-mani",fullName:"Anitha Mani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"SRM Dental College",country:{name:"India"}}},{id:"355612",title:"Dr.",name:"Janani",middleName:null,surname:"Karthikeyan",slug:"janani-karthikeyan",fullName:"Janani Karthikeyan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"SRM Dental College",country:{name:"India"}}},{id:"334400",title:"Dr.",name:"Suvetha",middleName:null,surname:"Siva",slug:"suvetha-siva",fullName:"Suvetha Siva",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"SRM Dental College",country:{name:"India"}}}]}},subseries:{item:{id:"90",type:"subseries",title:"Human Development",keywords:"Neuroscientific research, Brain functions, Human development, UN’s human development index, Self-awareness, Self-development",scope:"